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Atherosclerotic plaque disruption leading to thrombosis has traditionally been studied as a
rupture of a thin fibrous cap over a lipid-laden necrotic core. However, two noteworthy categories
of plaques that do not rupture have presented themselves: 1) in mice, plaque rupture is rare if not
absent, and 2) in humans, some plaques erode and form a thrombus without rupturing. Current
understanding of the biomechanical differences between plaques that rupture and those that do not
is incomplete. In this research, we used patient-specific computational biomechanics tools to study
differences among these groups.
Lesion-specific solid mechanical modeling of murine plaques revealed that the relative distri-
bution of stresses differs considerably between mice and man. In human vulnerable plaques, peak
stresses are on the thin fibrous cap over a necrotic core, but in mice the highest stresses are in the
media and adventitia, away from the plaque. Whereas atherosclerotic human arteries usually expe-
rience neointima formation around the entire circumference of the vessel, mouse plaques tend to be
punctate and adjacent lesion-free regions. The difference in mechanical environment suggests that
plaque rupture, if possible in mice, is likely not driven by mechanics in the same manner as humans.
Similar mechanical modeling of human ruptured and eroded plaques and comparison to histo-
logical staining revealed that ruptured plaques exhibit increased levels of inflammatory markers in
response to strain in ruptured plaques, but no such response was observed in plaque erosion. This
suggests that treatment of inflammation, a current paradigm for care of atherosclerotic patients,
may not be an effective approach to mediate plaque erosion. Computational fluid dynamics mod-
eling of patients with plaque erosion revealed no relation between wall shear stress magnitude or
direction, further suggesting that the mechanism of plaque erosion differs considerably from that
of plaque rupture. Together, these findings suggest that biomechanics can help explain why not all






Heart disease and its associated comorbidities are the leading killer in the modern world. Today,
almost twice as many women die of heart disease than from all kinds of cancer combined [1].
Atherosclerosis is no modern phenomenon: analysis of Egyptian mummies from thousands of years
ago when diet and exercise patterns differed considerably from modern routines reveals evidence
of advanced lesions [2]. The disease is essentially unavoidable: early-stage lesions can be found in
many individuals starting as early as infancy [3]. When a plaque progresses to an advanced stage,
it could cause a blood clot called a thrombus to form and occlude blood flow. Despite decades of
research into cardiovascular disease, we still cannot accurately predict when a heart attack or stroke
will occur, and patients who have had events are at high risk for recurrence [4]. There is ongoing
need for a better understanding of how plaques progress to form a thrombus and predict events
before they occur in diseased individuals.
Among the most common techniques to study this disease are the atherosclerosis-prone mouse
models. These animals rapidly and reliably form atherosclerotic plaques under specific condi-
tions, although rodents are naturally resistant to vascular disease. Despite their prevalence in the
atherosclerosis literature for studying processes of atherogenesis and atherosclerotic burden, no ro-
dent model has been shown conclusively to reproduce spontaneous plaque rupture, the process that
causes heart attack or stroke. Existing reports of spontaneous rupture are controversial [5–7], and
without confirmed reports of this event, the models may not be ideal for studying endpoints of
atheroscelerosis.
1.2 Layers of arteries
Arteries are made of three layers: the intima, media, and adventitia. In healthy individuals, the
intima is a monolayer of endothelial cells lining the lumen of the blood vessel [8]. Endothelial
cells present an anti-thrombogenic surface to the blood pool such that blood can flow and transport
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nutrients without clotting under normal circumstances [9]. In atherosclerosis, a “neointima” layer
expands below the endothelial monolayer [10]. Outside the intima is the media, a ring of smooth
muscle cells that gives blood vessels most of their compliance, as well as the ability to dilate or
contract. Outside the media is the adventitia, a ring of fibrous tissue, mostly collagen, that gives
the vessel support and a surface by which to tether onto neighboring tissue. The adventitia is a
the location where some inflammation is initiated and the source of approximately half the cells
comprising the neointima [11]. Between each of the three layers in humans is an elastic lamina, a
fenestrated tube of elastin that further adds to the vessel’s compliance and separates the different
tissue layers [12]. In other animals such as rodents, multiple elastic laminae are present inside the
media, although the exact reason for this is not well understood.
1.3 Progression of Atherosclerosis
Atherosclerosis is a complex pathology, with multiple risk factors and several stages of progres-
sion. All blood vessels become more fibrous with age, a process called arteriosclerosis [10], but
atherosclerosis is a specific process of lesion formation that occurs preferentially in specific sites:
mostly the coronary arteries, inner curvature of the aortic arch, carotid bifurcation, and around the
renal arteries in the descending aorta [13]. Two classification schemes dominate existing literature:
the American Heart Association (AHA) and widely accepted Virmani schemes [3, 14, 15]. The for-
mer was developed by a council of researchers in 1994 and contains 6 stages. The latter is a revised
scheme based on more modern histological findings. Both are useful for understanding the disease.
1.3.1 The American Heart Association classification scheme
The American Heart Association classification describes a range of developmental steps from the
initiation of lesions to development to advanced stages [3,14]. At Stage I, lesions are initiated. The
mechanism for this is not precisely known, but it is thought to involve endothelial injury, cholesterol
accumulation in the matrix of vessel walls, or adventitial inflammation [11]. Immune cells called
monocytes enter the region and differentiate into macrophages. Some engulf plasma-derived oxi-
dized LDL in the wall and become engorged with lipid droplets [16]. These cells, called foam cells,
are clustered within a distinct region. AHA Type I lesions occur mostly in infants and very young
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children, though they can be found in some adults in regions not typically predisposed to lesion
formation.
The next stage of atherosclerosis is production of fatty streaks, classified AHA Type II, also
known as xanthomas (defined as “focal accumulations of fat-laden macrophages”) [15]. Foam cells
form larger clusters than in stage I, and smooth muscle cells here also contain lipid droplets. The
AHA subclassifies these into progression-prone (Type IIa) and progression-resistant (Type IIb) le-
sions. The two subclasses are morphologically different: progression-prone lesions contain more
smooth muscle and foam cells. Type IIb lesions are not considered likely to advance, although
fluid dynamics are the greatest determinant of lesion progression (see section 1.8). Type II lesions
typically emerge around puberty in humans.
In AHA Type III lesions, there is pronounced pathological intimal thickening. These are also
called intermediate lesions or “preatheromas”. Here, the lipid droplets in smooth muscle cells have
progressed to form pools of extracellular lipid, substituting the extracellular matrix that normally
holds these cells together. The lipid pools are not yet organized into the large, confluent lipid core,
but have more lipid than Type II lesions. Additionally, free cholesterol is present. Type III lesions
are typically found in young adults. They may progress to Type IV.
At Type IV, also known as an “atheromatous plaque”, lipid pools merge to form a large confluent
lipid core [14]. Atheromas are usually located where intimal thickening occurred in stages I-III,
leading to an eccentric lesion. Smooth muscle cells disperse and get replaced by fibrous tissue.
Because the wall is so thick at this stage, blood vessels called vasa vasorum expand and become
more developed within the wall of the artery to better supply nutrients to the tissue.
From Type IV, the plaque may or may not progress into one of three subclassifications of Type
V lesions. Type Va (or sometimes simply Type V) is the fibroatheromaa type IV plaque that has
added more fibrous tissue while retaining a large lipid core. Multiple cores separated by fibrous
tissue are possible. Type Vb (also called Type VII) lesion are calcified, and Type Vc (or Type VIII)
lesions have most of the lipid replaced by fibrous tissue.
The final stage recognized in the AHA scheme is Type VI, although it should be noted that few
plaques progress to this stage, and some that do may heal and return to Type V. Type VI is a plaque
with histological evidence of plaque disruption: hematoma (Type VIa), hemorrhage (Type VIb), and
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thrombus (Type VIc). When vasa vasorum becomes disrupted, hematoma or hemorrhage result. A
thrombus is a blood clot in the lumen that partially or completely occludes blood flow. Type VI
plaques are frequently subclinical but are thought to be the most common cause of myocardial
infarction and stroke.
1.3.2 The Virmani classification scheme
To reflect shortcomings of the AHA classification scheme, Virmani and colleagues developed an-
other scheme to describe atherosclerotic lesions [15]. For example, the AHA scheme does not
differentiate between plaques based on fibrous cap thickness, although this feature can greatly affect
the clinical relevance of the lesion. Therefore, they modified the AHA scheme according to the
following criteria.
First is the initial xanthoma, similar to Type I plaques. These are characterized by lipid-laden
macrophage accumulations and frequently regress. Next comes intimal thickening, which is mostly
fibrous neointima tissue buildup from the site of xanthoma. Minimal cell replication occurs at this
stage, although it is worth noting that most smooth muscle cells are clones of one another at this
point. Eventually, intimal thickening becomes pathological when lipid and foam cells begin to
accumulate alongside this fibrous tissue.
The most important features of the Virmani classification scheme are in fibroatheromas. Al-
though the AHA types IV and Va plaques both describe fibroatheromas, these imply a series of
events in fibrous cap formation and lipid core expansion that may not be correct in the scheme of
plaque progression. Therefore, the Virmani scheme adds the thin-cap fibroatheroma (TCFA) as a
new category not recognized in the AHA scheme where the fibrous cap is < 65 µm thick. These
plaques are known to be likely to rupture and are sometimes called “vulnerable plaques” [17]. If
a fibroatheroma contains a necrotic core that is thicker than this threshold, it is called a thick-cap
fibroatheroma (ThCFA).
1.3.3 Composition of plaques
Atherosclerotic plaques are composed of a complex milieu of inflammatory cells, synthetic smooth
muscle cells, collagen, proteoglycans, oxidized lipid, and calcification, among other things. Al-
though lesions are extremely heterogeneous, specific regions of the plaque tend to be composed
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of specific components. Fibrous tissue, which comprises a large portion of the neointima of most
plaques, is mainly formed from synthetic smooth muscle cells that have abandoned their contrac-
tile phenotype and migrated out of the media. Multiple types of collagen, including Types I and
III, make up this fibrous layer. Fibrous tissue also may accumulate in response to vascular injury
through a process called intimal hyperplasia, but this is a different phenomenon than atherosclerosis.
During pathological intimal thickening, lipid, particularly oxidized low-density lipoprotein (LDL),
begins to accumulate within the vessel wall [16, 18]. This tends to accumulate in neointimal lipid
pools, which are proteoglycan-rich regions interspersed with lipid that have a gelatinous texture.
This lipid may be consumed by macrophages, but many macrophages become engorged with LDL
they cannot process and die. This, in turn, attracts more macrophages to the region, and after enough
foam cells die, the region becomes a necrotic core [19]. A necrotic core is a mixture of lipid once
contained within living foam cells and other necrotic tissue. At the periphery of the necrotic core
may be more, living macrophages or even smooth muscle cells building fibrous tissue around the
necrotic core. Microcalcifications may form when cells die, leaving behind accumulated calcium
from their mitochondria [20].
1.4 Endpoints of atherosclerosis
1.4.1 Vulnerable plaques
The so-called “vulnerable plaque” (Figure 1.1), stage IV or Va in the AHA scheme and called the
thin-cap fibroatheroma in the Virmani scheme, is currently thought to be the most important stage
for preventing morbidity and mortality [17]. A vulnerable plaque is not necessarily dangerous on
its own, but it can sometimes progress to a ruptured plaque for reasons that are not well understood.
Many vulnerable plaques will never progress to rupture, but because we cannot yet predict exactly
which plaques will cause clinical events, identification of a vulnerable plaque is typically grounds
for immediate medical intervention. Identification of a vulnerable plaque in vivo is a process still in
its infancycurrent techniques are mostly invasive and still imperfect [4].
In a TCFA, a thin fibrous cap (defined as being < 65 µm) must be present over a lipid-rich
necrotic core [21, 22]. If this fibrous cap breaks open, the plaque will have ruptured. Although
a vulnerable plaque may progress to fatal rupture, it is not necessarily a “large” plaque. Many
5
Figure 1.1: Atherosclerotic plaques can be classified into three groups. Left, an undisrupted vul-
nerable thin-cap fibroatheroma (TCFA) plaque exists within the vessel wall but has no thrombus
associated with it. If a fibrous cap over a necrotic core breaks open and a thrombus forms, the
plaque has ruptured (middle). If a thrombus forms over an atherosclerotic plaque without breakage
of the fibrous cap, erosion has occurred (right)
highly stenotic plaques are quite stable, whereas minimally stenotic plaques can often be vulnera-
ble [23]. Although vulnerable plaques are an advanced stage of atherosclerosis clinically speaking,
one should not conflate or confuse “advanced” with “large”. This makes their identification difficult
using techniques such as angiograms, which are only sensitive to visible stenosis. Other causes of
thrombosis such as plaque erosion and calcified nodules likely have their own vulnerable pheno-
types, but how these would be classified is not currently known (for example, eroded plaques could
be classified as AHA Types IV, Va, or Vc).
1.4.2 Plaque Rupture
If a plaque breaks open, a blood clot called a thrombus can form and occlude blood flow, leading to
a heart attack or stroke [13]. For a plaque to rupture, the fibrous cap over a necrotic core fissures,
exposing the necrotic core (a thrombogenic substance) to the blood pool [24]. Plaques currently
thought most likely to progress to rupture are the thin-cap fibroatheroma phenotype [17]. The
rupture site is usually directly on the thin fibrous cap or on the shoulders of the plaque, the region
where the fibrous cap ends and connects to the rest of the vessel wall [25]. This is frequently an
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acute event, although often ruptures can heal without causing morbidity or mortality [26]. Layered
plaques due to healed rupture are frequently observed in pathology studies [6]. The exact frequency
of non-fatal rupture is not known, but when a non-occlusive thrombus forms, it can heal as smooth
muscle cells enter the thrombus and begin synthesizing fibrous tissue. This leaves behind a fibrous,
and often highly stenotic, region with layers of fibrin and platelets from the original thrombus in
between.
Inflammation is a key factor in the development of atherosclerotic plaques [27]. Not only are
inflammatory cells essential for the formation of a necrotic core, but they also affect vascular remod-
eling and predispose certain lesions to rupture. The necrotic core is formed by foam cells, which
migrate into the neointima of vessels and release their lipid-laden contents upon death. The defini-
tion of rupture requires a necrotic core, so lesions without one cannot rupture. Inflammatory cells
don’t just form this core, however. They also attack or induce apoptosis in synthetic smooth muscle
cells forming the fibrous neointima [28, 29]. Without these cells, a fibrous cap thins and weakens,
creating a mechanical environment ideal of rupture to occur. For more on the role of mechanics in
plaque rupture, see section 1.9.2.
1.4.3 Plaque Erosion
In contrast to plaque rupture, plaque erosion is a relatively recently-discovered phenomenon [30].
Here, a thrombus forms directly over an atherosclerotic plaque, but the plaque remains undisrupted
[31]. This thrombus formation may not be an acute event, and instead may accumulate over a
period of weeks to form a mural thrombus [32, 33]. Despite identification, the mechanism for
plaque erosion is not well understood. Its prevalence seems to be highest in women and in young
men who are traditionally considered to be at lower risk for heart disease [17]. For many of these
patients, the first symptom of coronary disease is death. This pathology was first noted in 1994 by
van der Wal and colleages and then characterized more comprehensively by Virmani and colleagues
in 1996 [30, 34]. These initial descriptions are relatively recent, in part because many early studies
of heart disease specifically included only male coronary specimens in order to rule out hormonal
effects. An unintended consequence of this selection in these early studies was the omission of
plaque erosion candidates from study groups.
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Plaque erosion is named such because a likely mechanism is endothelial denudation, where the
endothelial cells “erode” away for currently unknown reason and expose the collagen and extra-
cellular matrix beneath the cellsa thrombogenic surface [35, 36]. These cells may be lost due to
localized apoptosis, but the specific mechanism for induction of denudation in erosion is a topic
of current research [37]. In rabbits, localized incubation of the femoral artery with staurosporin in-
duces apoptosis. This leads to denudation and thrombosis, offering a putative animal model for later
stages of plaque erosion [37]. However, the mechanism for spontaneous apoptosis over plaques in
humans is not clearly known.
Hypocholorous acid made by macrophages is also known to induce endothelial apoptosis in
high concentrations, or to trigger endothelial cells to release tissue factor under lower concentrations
[38]. Endothelial cells may also be lost as result of destruction of the basement membrane of these
cells by proteinases such as MMPs or cathepsins [39, 40]. It has been noted that hyaluronan and
proteoglycans like versican tend to be present at sites of plaque erosion. These extracellular matrix
proteins may offer an optimal substrate for aggregation of thrombus [36]. Other possible causes of
denudation may include vasospasm or highly shearing flow [41, 42]. Plaque erosion may also be,
at least in part, a consequence of blood clotting disorders (which increase likelihood of thrombus
formation). Proposed mechanisms include elevated levels of circulating tissue factors or suppressed
fibrinolytic mechanisms [27, 43].
1.4.4 Calcified Nodule
A much less common but still noteworthy cause of coronary thrombosis is that of a calcified nodule
. Much as in stage Vb of the development of atherosclerosis intra-plaque macrocalcification forms.
If this calcification erupts from the plaque, it presents a thrombogenic surface to the blood pool.
One study identified these as being mostly located in the mid-right coronary artery and suggested
that torsional stress might play a role [15].
1.5 Vessel remodeling
As an atherosclerotic lesion grows, it adds thickness to the wall of the artery. There are two phases
to this process, termed Glagov remodeling [44]. First, the vessel experiences “outward remodeling”
where the plaque thickens by increasing its exterior diameter rather than its interior diameter. The
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cross section of the lumen is approximately preserved even as the wall thickens in this phase. The
media frequently breaks down and becomes fibrous tissue as this happens. Next, after the plaque
burden has reached about 40% (meaning 40% of the area inside the exterior border of the vessel is
made up of plaque and media), the vessel undergoes “inward remodeling”. Inward remodeling is
when the plaque actually protrudes into the lumen.
When the lumen diameter is changed, we call this a stenosis. Whereas in outward remodeling
a plaque exists but does not impede blood flow, stenotic inward remodeling can actually change
blood flow [45]. Any constriction of flow results in a pressure drop across the obstacle. Not only is
pressure lost but also this region accrues unique hemodynamic properties, discussed in section 1.8.
In short, wall shear stress increases across the stenosis, and if the stenosis is severe enough, reversed
flow could result downstream [13].
1.6 Thrombosis
A thrombus is a blood clot. The process of forming a thrombus is called thrombosis, and if the
thrombus embolizes (breaks off and is carried in the blood stream), it could travel downstream
and obstruct a smaller vessel [35]. The human arterial tree is a series of vessels whose diameter
decreases distally, so an embolized thrombus could obstruct any variety of small vessels depending
on its site of origin and local hemodynamics [13]. Frequent sites of concern include the brain
(where the embolism causes a stroke), the heart (a myocardial infarction) or the lung (a pulmonary
embolus).
Alternately, a thrombus can stay in situ and create a stenosis or obstruction. Any occlusion
of blood flow can result in decreased nutrient transport or, if upstream pressure is high enough, a
jet that causes downstream endothelial damage or hemolysis [9]. Thrombus formation can be acute
(forming in seconds to minutes) or chronic (days to weeks) depending on circumstances surrounding
thrombus formation.
After a thrombus forms, it can heal or form an “organized thrombus” made of layers of smooth
muscle cells, proteoglycans, and fibrin [15,32]. This can result in formation of additional neointima
and further narrowing of the lumen.
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1.6.1 Virchow’s triad
Typically, a thrombus forms for 3 reasons, described by Virchow’s triad. These factors are hyperco-
aguability, stasis, or endothelial damage. The first is not typically related to atherosclerosisaltered
blood composition like increased activity of clotting factors is usually the cause. Stasis of blood (or
turbulence, another possibility) are only indirectly related to atherosclerosis. If a plaque is severely
stenotic and creates an eddy region downstream, blood stasis is possible [46, 47]. Similarly, a
severely stenotic vessel due to atherosclerosis could result in turbulent flow, but this too is a rare
situation [35, 48].
The third piece of the triad, endothelial damage, is the most closely associated with atheroscle-
rosis. When a plaque ruptures, it exposes collagen fibrils from the newly-broken fibrous cap [13]. It
also allows necrotic core to come into contact with the blood pool, providing a thrombogenic seed
point [43]. In plaque erosion, endothelial cells may be lost, and the underlying collagen and elastin
serves as a site for thrombus formation [36, 49].
1.6.2 Plaque imaging
Because atherosclerosis is such a significant cause of morbidity and mortality, there is significant
interest in detection of plaques both for study and for prevention and treatment. Numerous imaging
techniques exist, each with unique benefits and drawbacks.
1.6.3 Angiography
Perhaps the simplest and most prevalent technique to assess atherosclerotic burden of patients is
a technique called angiography. Angiography literally means imaging of blood vessels and could
describe a multitude of techniques, but when used alone the term is implied to mean a projectional
radiography image of blood vessels. In angiography, a patient receives a dose of radio-opaque con-
trast agent, and then an x-ray image of blood vessels is acquired. This could be captured on film
as a still image (as was done historically) or via fluoroscopy, where a movie of blood vessels is ob-
tained with a fluoroscope. In modern practice, fluoroscopy is typically performed in catheterization
labs where a catheter is threaded into the system of interest (for example, the coronary arteries, the
cerebral circulation, or the aorta) and a time-lapse image of blood flow is acquired by injecting a
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known dosage of a contrast agent into the circulation. One can roughly estimate blood velocity from
fluoroscopy by timing the distance an injection of contrast travels.
In these images, physicians are looking for any narrowing of the vessel lumen that would indi-
cate the presence of a stenosis [50]. The contrast agent used only enters the bloodstream and does
not get absorbed into the wall, so physicians use angiography to image the cross-sectional diameter
and path of blood vessels. Because of Glagov remodeling, many clinically relevant lesions can be
missed by angiography [50]. If a vessel is only remodeling outward and yet has formed a thin-cap
fibroatheroma, the patient could conceivably experience plaque rupture from a lesion invisible to
angiography.
Similarly, an angiography image can only visualize vessels perpendicular to the path of the x-
ray beams. Because many plaques are eccentric, one view could reveal no evidence of lesion and
yet an orthogonal view could reveal significant stenosis. For this reason, most clinicians obtain a
minimum of two unique views of vessels (called bi-plane angiography) [51]. Using more advanced
technology, clinicians can now use “rotational angiography” where an x-ray angiography system
on a C-arm can collect multiple views of the vessels and then reconstruct the vessels in 3D. This
is similar to the idea behind CT imaging, although CT uses radon transforms of x-ray scattering to
perform its reconstruction and rotational angiography uses a large number of planar x-ray images
to perform its reconstructions. Both techniques deliver a radiation dose to the patient and therefore
must be used sparingly.
1.6.4 Intravascular techniques
One of the most popular current techniques in cardiovascular diagnostics is intravascular imaging.
Here, a patient is sedated in the catheterization lab of a hospital, and a clinician feeds a wire through
the subject’s arteries from an access port, typically the femoral artery. On the tip of the wire the
clinician can thread interventional or diagnostic devices and guide them to the desired site using
fluoroscopy. Although any contact of the wire against the artery wall carries a risk of inducing
endothelial denudation or vasospasm, this approach successfully resolves myocardial infarctions
and strokes in most emergency situations.
Two catheter-based imaging techniques are most popular today: intravascular ultrasound (IVUS)
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and optical coherence tomography (OCT). IVUS is the most widely used in the United States at
present, though OCT is a technique currently making advances. IVUS uses ultrasound to bounce
high-frequency audio waves off the walls of blood vessels and collect back at the catheter tip [50].
Operating like radar, these waves reflect off both the surface of the lumen and off internal reflectors
inside the vessel wall, allowing the clinician to image both the lumen and the thickness of the wall
by timing how long it takes waves to bounce back. IVUS returns a single cross-section of the vessel
at a time corresponding to the axial location of the probe, so clinicians do a “pullback” where they
feed the IVUS catheter to the farthest desired location along the artery then acquire images as they
pull the catheter back toward the access port.
Traditional IVUS imaging returns the magnitude of the ultrasound pulse, providing a black-and-
white image of the vessel borders and information about strong reflectors like stents or calcification.
By also tracking the phase of backscattered waves, some systems provide “virtual histology” (VH)
revealing the spatial composition of the wall. Tissues such as lipid, fibrous, and calcification alter
the phase of the wave differently during each reflection [32,52]. Use of VH is becoming widespread
and is commercially available in FDA-approved systems such as those marketed by Volcano Cor-
poration (San Diego, CA). Additional techniques like near-infrared spectroscopy can be combined
with IVUS to interrogate the structure of the plaque [53].
One shortcoming of IVUS is its low spatial resolution, which cannot determine fibrous cap
thickness precisely. Especially given the threshold in the literature of 65 µm for fibrous cap thickness
with respect to vulnerability to plaque rupture, VH-IVUS cannot accurately study this parameter
with current spatial resolutions in the neighborhood of 200 µm. If VH-IVUS detects necrotic core
adjacent to the lumen, one can only assume it is overlaid by a fibrous cap thinner than this spatial
threshold [54]. However, OCT provides considerably higher resolution (approximately 10-20 µm)
and can be used to measure the cap thickness of TCFAs [54]. OCT maps vessels using the same
pullback technique as IVUS, but it cannot penetrate very far beneath the lumen, behind a thrombus,
or through blood (saline must be injected before performing OCT). Typically, signal loss is so great
that the exterior of the vessel cannot even be resolved; OCT uses visible light pulses to return
its signal, which simply cannot travel through dense tissue more than a handful of microns thick.
For this same reason, OCT cannot distinguish thrombus from tissue like smooth muscle; a mural
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thrombus prevents imaging almost any of the tissue beneath it.
A third catheter-based probe in use today is called “thermography”, which measures the temper-
ature of the wall to create a map of lesions [55]. The principle behind thermography is the notion
that inflammation causes atherosclerosis, and inflammation also warms tissue. The utility of this
technique is still under investigation, as the local temperature gradient due to an inflamed plaque
is currently below the level of sensitivity of probes. Additionally, the act of dragging a thermal
probe along the wall of blood vessels carries its own risk of endothelial denudation or even induc-
ing plaque rupture. This technique would be unable to detect lesions not heated by inflammation,
meaning many lesions could be missed.
1.6.5 Histology
Perhaps the highest-resolution technique to study blood vessels is histology. By viewing stained
tissue under a microscope, one can resolve features with submicron resolution. Histology is an ex
vivo technique, so it can only be performed on biopsy or autopsy tissue specimens. By staining
tissue with chromagens and/or antibodies, one can resolve detailed information on the presence and
distribution of proteins and compounds present in the tissue.
In order to stain tissues for microscopy, it must first be mounted. Thick sections of tissue are
often not optically transparent, making transillumination of stained features difficult. Confocal mi-
croscopy can optically section tissue to resolve some internal features, but light still cannot penetrate
through dense, thick structures. Therefore, to see inside of a harvested tissue, it is often prepared by
embedding in a mounting medium then sectioned using a microtome, often at single-digit micron
thicknesses, onto a glass slide.
Tissue can either be fixed or prepared fresh after harvest. Tissue fixed with agents like formalin
can be stored for long periods of time at room temperature, but not all antibodies can operate on
fixed tissue. Enzymatic assays like zymography also cannot be performed on fixed tissue. Fresh
tissue, on the other hand, must be analyzed immediately upon harvest or frozen for storage at -
80◦C. Frozen tissue is often prepared by embedding it in optimal cutting temperature (OCT, not to
be confused with the vascular imaging technique of the same acronym) medium then sectioning in
a cryostat. Frozen tissue sections are often the most compatible with commercial antibodies but
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experience considerable morphological distortion during sectioning. For whole-vessel imaging of
fresh tissue, en face preparations are common, where a vessel is sliced axially then flattened such
that the endothelium is exposed in a single plane.
For fixed tissue, paraffin wax embedding is common because of the ease of processing, but not
all commercial antibodies are compatible with paraffin embedding. Methyl methacrylate (MMA)
resin embedding is a more technically-complex technique that requires sectioning with a diamond-
blade microtome. The hard resin enables even sectioning through solid structures like vascular
calcification, and many antibodies compatible with paraffin sections will work with MMA [56–58].
Both paraffin and MMA embedding protocols typically require sending tissue through graded al-
cohols, a process that dehydrates tissue for storage but also dissolves away any lipid and prevents
direct detection of lipids. Glycol methacrylate (GMA) is another plastic resin that does not dena-
ture enzymes, but its use is technically complex, it is incompatible with many standard staining
protocols, and over time cures into a hard, un-sectionable block.
A large number of “special stains” are common in vascular research that exploit natural affin-
ity of specific tissue types for certain dyes. Perhaps the most universal stain is hematoxylin and
eosin (H&E), where nuclei are stained purple with hematoxylin and cytoplasm is stained pink with
eosin. Gross vascular tissue composition is often identified using Movat’s pentachrome or Masson’s
trichrome stains, which use multiple simultaneous dyes to color different components of vascula-
ture. Picrosirus red stains collagen pink, enabling identification of necrotic cores in atherosclerotic
plaques because of dull yellow staining in these regions. Under polarized light, the birefringent
properties of picrosirius red reveal large collagen fibers (Type I) in yellow/orange and thin fibers
(reticular fibers, Type III) in green. Other stains reveal specific tissue types, such as Von Kossa’s
calcium stain which identifies calcium in black or Verhoeff’s elastin stains that identifies elastic
lamina in black.
Immunohistochemistry (IHC) uses antibodies to detect and stain specific proteins. A primary
antibody is incubated on the tissue of interest such that it binds to its specific antigen. After washing
of excess primary antibody, a secondary antibody specific to an antigen on the primary antibody
(and hopefully not to any other antigens in the tissue) such as the Fc region is then incubated.
Finally, a fluorophore or chromagen is bound to the secondary antibody using a technique such as
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forming an avidin-biotin complex (although many other conjugation systems exist as well). In order
to improve primary antibody binding, particularly on fixed tissue, one must sometimes perform
antigen retrieval using pretreatment techniques like placing in boiling ethylenediaminetetraacetic
acid (EDTA), or digestion in proteinase K. These techniques improve staining efficiency but may
introduce tissue artifacts. The mechanisms of some antigen retrieval techniques, although effective,
are not completely understood.
In any type of histology, it is particularly important to include appropriate positive and negative
controls. These steps, sometimes inappropriately omitted, are critical to ensure the stain in ques-
tion is both specific and successful. Control slides typically contain identically-embedded sections
of tissue from well-characterized tissue types. Positive control slides ensure that the stain is func-
tioning and that it appears in expected tissue regions. Negative control slides ensure that positive
staining is not also observed in regions where it should not exist, perhaps because of nonspecific
staining of the chromagen/fluorophore directly to the tissue itself.
1.6.6 Other techniques
Magnetic resonance imaging (MRI) is a popular technique to acquire vascular anatomy and an
associated flow field. MR angiography (MRA) can use a variety of scan sequences to image blood
vessels, with each type of scan offering benefits and drawbacks [59]. For example, 3D time-of-flight
(3D-TOF) MRA is a popular technique that allows imaging of the blood pool because blood returns
a bright signal [60]. This is useful for determining the lumen of blood vessels, although 3D-TOF
sequences are not well suited for imaging the wall itself and cannot resolve blood not leaving the
plane of the image (for example, through swirling flow). Conversely, black-blood sequences return
poorer resolution of the lumen border but allow viewing of the thickness of the blood vessel itself.
Multi-sequence techniques have been proposed that attempt to return not only information on the
lumen and wall thickness but even the composition of the wall itself [61, 62]. These techniques are
controversial.
To improve visibility of blood in MR scans, contrast agents like gadolinium are often injected.
Gadolinium alters the relaxation time of atoms in the blood and enhances vasculature. At the frontier
of vascular MR imaging is the use of paramagnetic nanoparticles as a contrast agent [25]. These
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particles, wherever present, alter the local brightness of an MR signal and offer promise to detect
features of atherosclerotic plaques. Other molecular contrast agents have been proposed that will
bind to thrombus for non-invasive detection [63].
Another benefit of MRI, besides that it provides zero ionizing radiation dose to the patient, is
that it can image blood velocity, a useful tool for researchers studying both anatomy and blood
flow. Using phase-contrast MR (PCMR), a patient’s vessel anatomy can be acquired with MRA,
and then in the same scan session the corresponding velocity field can be obtained as well [49, 64].
PCMR can only acquire blood flow in a single direction through a single slice at a time, though, so
a researcher interested in the full 3D path of blood in a single slice would need 3 scans to acquire
x, y, and z-components of velocity. This can be time-intensive since the patient must remain still in
the scanner, but the advantage is accurate registration of velocity data with respect to anatomy.
Computed tomography (CT) imaging can provide an even higher resolution angiogram than
MRI, although CT uses x-rays for imaging and thus carries a radiation dosage to the patient. Also,
no PCMR equivalent exists for CT, so there is no way to measure flow using the technique in patients
receiving a CT angiogram. A benefit of CT is a purported ability to identify and look inside soft
plaques.
1.7 Animal models of atherosclerosis
Because much work is yet to be done to understand the pathogenesis of atherosclerosis and develop
treatments, animal models are an attractive tool because they recapitulate some of the processes of
atherosclerosis under controlled circumstances. In humans, imaging plaques is challenging, as each
technique carries limitations, and many experimental studies such as inducing plaque rupture would
be simply unethical.
A variety of animal models have been developed, and these too carry benefits and limitations.
Mice and rats are among the most popular models in use today. Because rodents are naturally
resistant to atherosclerosis, additional measures must be taken to induce atherosclerosis, including
genetic modification, diet, and pharmaceutical modifiers [65, 66]. Rabbits, dogs, pigs, and primates




Mice are perhaps the most popular animal model of atherosclerosis, since they rapidly and reliably
form plaques under certain conditions. More varieties of genetically modified mice are available
than for any other animal species at this time, and the two most ubiquitous mouse model strains
are the apolipoprotein E (ApoE-/-) and low density lipoprotein receptor (LDLr-/-) knock-out strains.
The LDLr-/- mouse is a more moderate model: it will not form plaques unless also fed a high-fat
diet [66]. The ApoE-/- mouse is a more aggressive model which will spontaneously develop lesions
without the addition of a high fat diet.
Multiple diets exist for these mice. Beyond the regular chow diet, the Western diet and the
Paigen diet (also called atherogenic diet) prevail in the literature [65, 69]. These differ in their
lipid composition. Diets can also be supplemented with simultaneous subcutaneous infusion of
Angiotensin II (AngII) via osmotic minipump, which makes the mice hypertensive [69]. AngII
alone has been shown to increase the severity and distribution of lesions [70]. Other important
factors that affect lesions in mice are age (older mice have greater plaque burden), gender (ApoE-/-
female mice have more severe lesions than males), and stress (stressful conditions like electric
shocks have been shown to increase lesion severity) [65, 66, 68, 69].
Additionally, because of the role of fluid dynamics in developing atherosclerosis (see sec-
tion 1.8), lesions can be induced by introducing a stenosis. Several techniques have been proposed,
including an external gradually narrowing cast and a nitinol shape-memory clip [71, 72]. Down-
stream of a stenosis, lesions increase, even in locations not typically prone to atherosclerosis. With
any type of manmade device introduced into a body, care must be taken to separate effects of the
device from effects of immune response to a foreign body.
Although mice are frequently studied as an analog of human atherosclerosis, considerable dif-
ferences exist between the two species [73]. Besides the fact that the two species are genetically
distinct (and thus produce different proteins), there are also discrepancies in size (a human aorta
is more than an order of magnitude larger than a mouse’s), the location of atherosclerotic plaques
(coronary lesions are not as common in mice as in men), posture (humans are upright and mice are
prone, leading to different fluid flow patterns and aortic curvature), and timescale of atherosclerosis
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(human lesions develop over decades whereas murine lesions develop over weeks).
One of the most noteworthy consequences of these differences is the difference in plaque rupture
between species. In humans, plaque rupture is of serious concern, but in mice, there is considerable
debate as to whether plaques ever rupture at all, let alone the physiological relevance of this rupture
to humans [5, 6, 74]. Some postulate that plaques do rupture frequently in mice, attributing their
layered appearance as evidence of past ruptures [7]. Others dismiss reports of rupture in mice,
suggesting most reports can be attributed to sectioning artifact or intraplaque hemorrhage [75, 76].
Nonetheless, the debate continues, and the consequence of this uncertainty is that many studies
report “rupture” as well as “vulnerable” and “unstable” lesions in mice despite imprecision of these
terms [77].
1.8 Fluid dynamics and atherosclerosis
1.8.1 Wall shear stress
Throughout the history of atherosclerosis research, multiple hypotheses have been presented to
explain why humans get atherosclerosis. Early hypotheses included immune function and dietary
cholesterol, but in the 1980s, Giddens and colleagues came up with a new hypothesis that prevails
to this day [78]. It had been noted that lesions only form in specific locations such as in the coronary
arteries or the carotid bulb [9]. These locations are consistent between individuals, and there are
other locations such as the internal mammary artery which almost never carry any atherosclerotic
burden [79, 80].
Giddens’ group proposed that the fluid dynamics of circulating blood could explain the local-
ization of plaques, and this explanation is supported by considerable evidence to this day [81]. All
of the primary locations for plaques tend to be on the inner edge of curving vessels or immediately
downstream of vessel bifurcations [82]. As blood flows through a vessel, the frictional force of the
flowing blood exerts wall shear stress (WSS) against the endothelium [13].







where τ is WSS, µ is the dynamic viscosity of blood, dvdr is the strain rate (near-wall velocity gradi-
ent), and R is the vessel radius.
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Today, we now know that low WSS is correlated with atherogenesis, and high WSS tends to
be atheroprotective [42, 83, 84]. WSS magnitude is not the only condition to note, however. Di-
rectionality also seems to play a roleoscillatory flows may have high instantaneous WSS, but if the
flow reverses for enough of the cardiac cycle, it could have low mean magnitude [42]. Thus, current
thinking is that both low magnitude unidirectional and low average magnitude oscillatory WSS are
atherogenic.
A stenosis typically creates complex fluid flow conditions, and thus may create a feedback loop
for plaque formation. As a stenosis narrows an artery, wall shear stress increases across the neck of
the stenosis. Downstream, low WSS appears, and if the stenosis is severe enough, oscillatory flow
may even appear [85]. This may provide a mechanism for plaques to grow from their downstream
edge and minimize continually increasing the degree of stenosis inward rapidly. In endothelial
cells, apoptosis tends to be higher in regions of low WSS and lower in regions of high WSS [86].
However, plaques are typically well-bounded and don’t grow forever, so WSS alone cannot explain
atherogenesis.
At the inner edge of curving vessels such as the inner curvature of the aortic arch, low and
possibly even oscillatory WSS dominates, whereas the outer curvature experiences higher WSS as
flow rounds the bend and runs into the outer curvature. At bifurcations, depending on the geometry
such as angle and diameter of the vessel, oscillatory flow such as that observed in the carotid bulb
is often expected on the outer edge immediately distal to the bifurcation.
1.8.2 Other metrics
To measure oscillation, a metric called oscillatory shear index (OSI) has been proposed, although
different groups have different specific definitions [81, 87, 88]. Despite technical differences, the
common theme for all definitions is that OSI measures how much the flow reverses direction over
each cardiac cycle. We prefer the definition of Moore et al. because of its range from 0 to 1 (enabling
easy logical interpretation as a percent) and its dependence on local mean flow direction (removing
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WSS is the wall shear stress vector, and H(x) is the Heaviside unit
function.
OSI is a metric of interest because it helps identify regions where flow is changing direction.
Whereas in laminar, unidirectional flows, low mean WSS implies low blood velocity close to the
wall, mean WSS could be low despite high instantaneous blood velocities if the flow reverses direc-
tion. Regions of low WSS and oscillatory flow are associated with progression of atherosclerosis,
but mean WSS alone is not the sole factor affecting vascular disease [9]. Experiments have shown
a different phenotype of lesions in mice between low unidirectional and oscillatory flow conditions,
and a variety of inflammatory proteins, reactive oxygen species, and micro-RNAs have all been
shown to be differentially regulated by laminar and oscillatory shear in vascular cells [71, 90].
Other metrics have been proposed that may also explain the localization and progression of
atherosclerosis [91]. Rather than investigating the raw magnitude of WSS, the spatial and/or tem-
poral gradient of WSS may be more important because these measure how WSS changes relative
to a local baseline. Additionally, measures such as relative residence time, vorticity, and helicity
could play a role in plaque progression and disruption, although such a link is not yet well estab-
lished [91, 92].
1.8.3 Mathematical and computational methods
Fluid flows are governed by a mathematical framework called the Navier-Stokes equations [93].
These describe how any fluid moves, although they are a series of differential equations that cannot
be easily solved except under idealized situations; an analytic solution of the full Navier-Stokes
equations is the topic of the Clay Mathematics Institute’s Millenium Prize for outstanding problems
in mathematics.
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Instead, to study subject-specific flows, we use a technique called Computational Fluid Dynam-
ics (CFD) that approximates a solution to the Navier-Stokes equations, given geometric and fluid
property bounding conditions. CFD is a powerful technique, but it requires careful selection of
numerical algorithms to accurately recapitulate the situation at hand. Many of the factors driving
these selections are tradeoffs between physiological accuracy and computational efficiency. For
example, the numerical method for solving the equations could use a direct approach (solving the
matrix equations using linear algebra techniques) or an iterative approach (approximating the solu-
tion with multiple guesses). Many vascular CFD problems require an iterative solver because the
computational cost of an explicit (direct) solution method is infeasible.
A common assumption in CFD is to represent blood as a Newtonian fluid. Blood is composed
of liquid plasma, as well as solid components like red blood cells, platelets, and dissolved proteins.
Red and white blood cells are not distributed homogeneously throughout liquid bloodclose to the
wall, plasma skimming results in a locally nearly cell-free zone. Factors like shear thickening
can also affect apparent viscosity, and the Fahraeus-Lindquist effect (apparent viscosity goes down
with vessel diameter) dominates in narrow vessels like capillaries. Thus, blood is probably best
represented as a Casson fluid. However, it is mathematically much simpler and computationally
more efficient to represent blood as a Newtonian fluid. Studies have shown that approximating
blood as a Newtonian fluid alters WSS calculations by about 10% whereas geometric uncertainty
affected it by four times that amount [94].
Other efficiency and accuracy assumptions to consider in CFD include discretization of the
model. Patient-specific vascular flows can be digitized into a finite-volume mesh comprising the
flow field. If the mesh is too coarse, the final solution will not be accurate (or will not solve at all).
However, finer meshes require more memory and simulation time for CFD to complete, so a tradeoff
must be reached. Typically, mesh resolution will reach a point of diminishing returns where a higher
resolution significantly increases the need for solution resources without a comparable increase
in solution accuracy. Therefore, CFD operators will often perform a mesh-convergence study by
simulating the same problem with meshes of different resolution to ensure that their solution is not
affected by mesh resolution. Similarly, temporal resolution must be considered in unsteady flow
simulations: iterating through time too quickly will decrease the accuracy of the solution, but too
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slowly will create an unnecessary processing burden.
1.8.4 Boundary conditions
One decision necessary when setting up a vascular CFD simulation is how to mathematically rep-
resent blood flowing in and out of the vessel. At the inlet, a number of possibilities exist. Even
in patient-specific CFD simulations, true patient-specific inlet velocities are often not known. For
example, if vascular geometry was determined by CT, then no flow information could possibly be
obtained by that modality. PCMR techniques can acquire patient-specific velocity profiles, but the
spatial and temporal resolution is almost certainly below the spacing of the mesh and timestep. Usu-
ally, some sort of velocity waveform (velocity versus time) must be applied to a CFD model, but
this typically represents mean velocity in the vessel and does not carry information about the spatial
distribution of velocity. Thus, a cross-sectional velocity profile must be applied.
Four idealized velocity profiles are prevalent in fluid dynamics literature. The blunt flow pro-
file, where every point in a single cross-section has a uniform velocity, is typically applied in flow
extensions. Flow extensions allow the flow to develop such that it enters the region of interest in a
more plausible manner while maintaining the ease of implementation of a blunt flow profile. As the
no-slip condition for viscous fluids dictates that velocity must be zero at the wall, a blunt flow pro-
file clearly violates this assumption. Therefore, analysis of hemodynamic parameters should only
be performed outside the blunt flow region. Slightly downstream of a blunt flow velocity profile
one will find a plug flow profile, a nearly uniform distribution of velocity profiles across the cross-
section except at the walls, where velocity ramps down to zero. Plug flow represents flow that is not
fully developed and may be an appropriate approximation for the coronary arteries.
When flow can be assumed to be fully developed, it may be approximated with a parabolic
(Poiseuille) or Womersley velocity profile [95, 96]. Poiseuille flow is defined for steady flow sim-
ulations through a cylinder, neither of which assumption is directly applicable to pulsatile, patient-
specific flows through a blood vessel (which is cylindrical but not a mathematically perfect cylinder).
Womersley flow solves this pulsatility problem by introducing a Fourier series of Bessel functions to
represent a temporally-fluctuating velocity field. Each of these four simplified inlet velocity profiles
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carries a set of assumptions, and CFD operators must weigh the pros and cons of using each tech-
nique if a patient-specific velocity profile is not known. In our own studies of the carotid artery, we
found that the relative effect of each type of profile is much less than the influence of the variation
in geometry from patient-to-patient [97].
Another boundary condition to consider is the outlet. Velocity profiles are not usually prescribed
at the outlet because this would over-constrain the system and be nearly impossible to solve the
Navier-Stokes equations. Instead, pressure is typically prescribed at the outlet. If patient-specific
pressure is known, this can be applied, or a target flow rate can be approximated by dynamically
adjusting the pressure at each outlet. Otherwise, a pressure outlet may be set as “traction free”,
meaning the pressure is zero. Other boundary condition possibilities include Windkessel models
or higher-order circuit analogies, which prescribe dynamic pressures by defining a resistance and
capacitance to approximate downstream blood vessels.
1.8.5 Fluid-structure interaction
The next generation of CFD is called fluid-structure interaction (FSI, also standing for fluid-solid
interaction depending on who you ask). Whereas CFD only simulates the fluid side of things, we
know that blood vessels are compliant and that arteries distend in response to pressure. CFD can
include moving walls to simulate this pulsatility, but encoding this motion requires adjustment of
the mesh at each timestep. This mesh adjustment process can be extremely complex, particularly in
patient-specific models, and prescribing physiologically-relevant moving walls as pre-determined
input geometry is very difficult. FSI improves this process by dynamically computing the moving
wall by adding a viscoelastic or other solid mechanical model to dynamically adjust the geometry on
top of the CFD. Implementations of FSI are computationally expensive and carry a greater burden
of assumptions than CFD or computational solid mechanics alone, so this field is still maturing.
1.8.6 Fluid dynamics and plaque rupture
WSS may not only govern plaque development, but it may also play a role in atherosclerosis
endpoints. Several case reports suggest that plaque rupture occurs directly at the site of greatest
WSS [98, 99]. Although isolated case reports cannot explain a mechanism for this (and may be
polluted by publication bias), such interplay between fluid flow and thrombosis is not unexpected.
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Shearing blood exerts a force on vessel walls in addition to forces from blood pressure, so if a fi-
brous cap is already weakened, extra WSS could lead to plaque rupture. While WSS is known to
help predict sites of plaque formation, its utility in predicting which of those plaques will actually
rupture is not well established.
1.9 Solid mechanics and atherosclerosis
Another factor of note in atherosclerosis is that of solid mechanics. Solid mechanics is the study
of forces and stresses, and a pressurized blood vessel has complex solid mechanics. Atheroscle-
rotic plaques are made up of numerous componentsthey are a heterogeneous material. Each sub-
component has its own material propertiesitems like calcification are much stiffer than lipid [100].
Biological materials are viscoelastic, meaning that their properties depend on the rate at which they
are loaded as well as the composition of the material itself [101]. They typically exhibit nonlinear
material properties and anisotropy, meaning that they have different material properties in different
directions [102]. Given the composition of blood vessels including collagen and elastin fibers, such
a relationship is unsurprising.
1.9.1 Residual stresses
Vessel remodeling, particularly at different rates between layers of vessels, results in residual stress
accumulation within the wall [101]. The effects of residual stress are readily apparent in opening
angle assays [103]. If a ring of an excised artery is sliced axially, it will open up and form a
C-shaped piece when viewed from end. If the artery were stress-free, it would remain stationary
upon slicing, but differences in levels of residual stress between the intima, media, and adventitia
causes this opening. Fung and colleagues postulated that the opening angle assay reveals a stress-
free conformation of the vessel, but inhomogeneity of the vessel suggests that some residual stress
likely remains even in a sliced vessel [101,104]. Thus, an artery in vivo not only experiences stresses
resulting from blood pressure, but also residual stresses innate to the tissue.
1.9.2 Plaque rupture
When the local stress exceeds the ultimate stress threshold of a material, the vessel breaks, resulting
in a fissure [24]. This is how plaque rupture is thought to occur. Although plaque rupture is a
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complex, multifactorial process with plenty of biological risk factors, overall it is a mechanical
event: a material is breaking. Within existing literature, a threshold of >300 kPa will result in
plaque rupture, but this specific threshold is not well supported by evidence. It was proposed in
an early computational study then propagated by the process of citation until it became prevalent
in the literature despite minimal evidence from direct measurement [105]. Regardless of the exact
magnitude of the ultimate stress of plaque components, plaque rupture occurs because of a local
maximum of stress on the thin fibrous cap or plaque shoulders [106].
Multiple factors contribute to the mechanical environment that results in rupture [26, 106, 107].
The blood pressure of a vessel is what exerts most mechanical force on the plaque (the other being
residual stresses innate to the growing vessel). Higher blood pressures result in higher stresses in
the wall. Hypertension (high blood pressure) is generally a chronic condition, so blood vessels often
remodel themselves to redistribute the resulting internal stresses [108, 109].
Another major factor contributing to rupture is the geometry of the plaque. Plaques are made of
multiple tissues, including smooth muscle cells, macrophages, lipid, collagen, and elastin. The exact
shape, size, and distribution of these tissues, each of which has different mechanical properties, will
affect the stresses in the wall [23]. This is the reason that the thin-cap fibroatheroma is thought to
be the most vulnerable to rupture whereas a thick-cap fibroatheroma is not.
Several studies have investigated the effects of geometry [110]. It has been shown that showed
that the size of the necrotic core, the thickness of the fibrous cap, the presence of necrotic cores and
calcifications, as well as the shape and location of the necrotic core all modulate the mechanical
environment with implications for plaque rupture [23,110–112]. Another factor that could increase
likelihood of rupture is fatigue, where a tissue becomes weakened after repeated bending over mil-
lions of cardiac cycles [107].
1.9.3 Microcalcifications
An emerging concept in vascular biomechanics is that of microcalcifications [113]. These small cal-
cifications (single micron or smaller diameter) form when macrophages release calcium deposits,
typically on the outside edge of necrotic cores. Nucleation for microcalcifications are thought to
come from the mitochondria of dying cells, most likely smooth muscle cells in atherosclerotic
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plaques [20]. Macrocalcifications tend to form as “clouds” of microcalcifications around necrotic
core that eventually expand to build on top of the core. Whether this process is one of active or
passive calcium deposition is not currently known.
Weinbaum et al. proposed recently that microcalcifications may play a role in plaque rupture
as well. They hypothesized that microcalcifications within the thin fibrous cap of plaques creates a
local stress concentration, which leads to fissuring and rupture [113]. This may explain why some
TCFAs rupture and others do not: microcalficiations are not universally present, especially in the
fibrous cap [114]. Although the microcalcification hypothesis has theoretical backing, further study
is still needed.
1.9.4 Biological responses to mechanics
Biomechanics, particularly solid mechanics, are not only important for determining how tissue
breaks. They also impact how tissues develop, remodel, and die. Tissues actively respond to
mechanical inputs through the process of mechanotransduction, such as when vessels remodel in
response to local mechanics. Constituents of the cytoskeleton tethered to membrane-bound proteins
like integrins, or mechanosensitive surface receptors themselves deform in response to mechanical
loading or shear force across the cell. These, in turn, upregulate intracellular processes to produce
specific proteins. For example, matrix metalloproteinases (MMPs) that remodel extracellular matrix
are known to be upregulated in regions of high mechanical stress [39,56,115,116]. The transcription
factor nuclear factor kappa-B (NF-κB) is also upregulated by local elevation of mechanical stress (as
well as in response to cytokines and oxidized LDL, among other things). NF-κB is known to upreg-
ulate production of a large number of inflammatory proteins [117]. Mechanotransduction through
integrins, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, xanthine oxidase (XO),
G-protein coupled receptors (GPCRs), tyrosine kinase receptors (TKRs), and others, many proteins
involved in the progression of atherosclesis are directly and indirectly regulated by mechanics [52].
1.9.5 Computational solid mechanics
Like fluid dynamics, solid mechanics are governed by a series of constitutive equations based upon
fundamental mechanics like forces and momentum. Similar to CFD, studying patient-specific ge-
ometries using these equations is impractical since blood vessels never perfectly align with Cartesian
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or cylindrical coordinates. Therefore, computational solid mechanics techniques are used to esti-
mate local mechanics. Typically, finite element analysis (FEA) or a similar technique, finite volume
analysis (FVA) are used to break a region down into numerous small mesh elements and then solve
the governing equations at each element relative to its neighbors. A mesh face element is typically
a triangle or quadrilateral with 3 or 4 nodes at each corner, respectively, and a mesh volume element
is a polyhedron such as a tetrahedron (triangular faces, 4 total nodes) or a hexahedron (quadrilateral
faces, 8 total nodes). Higher-order elements may subdivide each edge of planar or volume elements
with additional nodes. Additional nodes add mesh resolution at the cost of increased computational
expense.
Like CFD, many assumptions are required for solid mechanical modeling of biological tissues.
Perhaps the single most important factor is the set of material properties applied to each tissue. Bi-
ological tissues are non-linear, viscoelastic, heterogeneous, nearly incompressible, and anisotropic.
These properties are difficult to simulate on a lesion-specific basis, so tradeoffs must be weighed
when formulating a solid mechanical model.
A variety of mathematical descriptions of the non-linear properties of vascular tissues exist.
These are typically described by their strain-energy functions, and a number of possible constitu-
tive formulations for hyperelasticity exist [12]. Most vascular and atherosclerotic tissues can be
approximated with a bi-linear model, however, as tissues tend to accrue very little stress for low
magnitudes of strain until a breakpoint is reached around 40 mm Hg of pressure, at which point
stress increases nearly linearly with increasing strain [100]. Anisotropy of these tissues dictates that
material properties have different effective magnitudes along different axes. Anisotropy is dictated
by factors like fiber direction, such as alignment of collagen fibers, sarcomeres, or elastic lamina.
Tissues are primarily composed of water, which is incompressible within the normal physiologic
range. Although this would imply that the tissues themselves are essentially incompressible, many
FEA solvers cannot tolerate this condition. Thus, a Poisson’s ratio of around ν=0.49 is typically
assumed. Atherosclerotic plaques are heterogeneousthey are not made of a single tissue type. Thus,
FEA models must either actively delineate different homeogeneous material properties for different
elements (and thus define whether any sliding can occur between adjacent regions) or use a rule-
of-mixtures approach to approximate material properties for elements containing multiple materials
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[56, 101].
When formulating a problem for FEA, one must define the problem’s geometry as well as its
boundary conditions. Sufficient boundary conditions must be defined to constrain the system. For
example, in a 2D planar loading problem, at least one node’s displacement must be constrained in
each dimension lest the model float freely in space and have too many degrees of freedom to success-
fully solve. Nodal rotation boundary conditions may be assigned as well. However, constraining too
many nodes may over-define the system and become difficult if not impossible to reach a solution.
Forces may be applied either at a specific point as a concentrated load or distributed along an edge
or face (in 3D). When relevant, other boundary conditions such as thermal, voltage, or magnetic
properties of the system may be applied as well.
In FEA simulations experiencing large deformations or employing non-linear material proper-
ties, the problem is said to be non-linear, and requires additional consideration to reach an accurate
solution. Among the most popular approaches for solving non-linear problems is the Newton-
Raphson procedure. Here, loads are incrementally applied to the system, effectively creating a
transient loading problem. For problems not modeling viscoelastic effects or creep, the speed of
loading will not affect the solution, and thus this technique simplifies the solution process. Much
like CFD, each step must be solved individually for the simulation to progress to the next. Conver-
gence criteria must be defined for any iterative procedure such that the model may progress to its
next step.
1.10 Summary
Atherosclerosis is a multifactorial disease that leads to a considerable portion of all deaths annu-
ally. A complex combination of biology and mechanics are known to contribute to the progression
and endpoints of the disease. Despite much focus by the research community, there is no cure for
atherosclerosis, and we cannot yet predict who will suffer an atherothrombotic event, nor when.
Well-characterized animal models are necessary to study the disease, and consideration into dif-
ferent phenotypes of the disease are necessary. Plaque rupture and plaque erosion tend to affect
different demographics, and their mechanisms likely differ. Future research to better identify, treat,
and eventually prevent atherosclerosis in humans will require focus and collaboration from both the
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biology and the mechanics communities.
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CHAPTER II
HYPOTHESIS AND SPECIFIC AIMS
Atherosclerosis, the formation of fibrous- and lipid-rich plaque on the walls of arteries, affects nearly
all adults in the Western world and is a significant cause of morbidity and mortality. While most
plaques cause no symptoms, any disruption of the plaque could cause a thrombus to form within
the lumen of the artery, potentially leading to a vascular event such as myocardial infarction or
stroke if the thrombus occludes blood flow. Plaque rupture, the event traditionally thought to be the
cause of atherosclerosis-related thrombosis, is known to occur as a result of the interplay between
biological and mechanical factors. Proteolytic enzymes such as matrix metalloproteinases (MMPs)
can weaken the cap of the plaque, and local mechanical stresses become so great at the surface that
the fibrous cap ruptures, exposing the thrombogenic necrotic core of the plaque to the blood pool.
However, two noteworthy exceptions to the plaque rupture phenomenon have presented them-
selves: plaques do not rupture in mice, and in humans, particularly women, some plaques will
erode and form a thrombus without rupturing. The objective of this proposed research is to inves-
tigate these exceptions to the plaque rupture phenomenon from both a quantitative histological and
a mechanical standpoint in order to provide insight toward the long-term goal of identifying and
treating plaques that are likely to cause thrombosis.
Clear biochemical and anatomical differences exist between mice and humans. Differences in
structure and shape of murine and human plaques may result in entirely different mechanical envi-
ronments that could explain the atherosclerosis-prone mouse model’s resistance to plaque rupture.
Similarly, differences in structure and shape of atherosclerotic lesions that become disrupted in hu-
mans may explain the phenomenon of plaque erosion and its noted prevalence in women. All plaque
disruption is a mechanical event, whether it is rupture of the fibrous cap or denudation of endothelial
cells on the surface of a plaque. Therefore, a comprehensive examination of plaque biomechanics is
essential to understand why some plaques erode, others rupture, and still others remain undisrupted.
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2.1 Central hypothesis
Plaques that do not rupture experience different hemodynamic and mechanical environments than
plaques that are prone to rupture.
2.2 Approach
Using a computational fluid dynamics (CFD) model of blood flow, we simulated wall shear stress
(WSS) distribution, and with an established finite element analysis (FEA) model, we computed
solid mechanical stresses within human coronary artery and mouse arterial walls. Both the CFD and
the FEA models simulated vascular biomechanical stresses on a lesion-specific basis. Our overall
approach was to use these models to evaluate how differences in plaque shape and composition
affect stress distribution and relate to plaque rupture and plaque erosion. We also proposed to
use quantitative histological staining to investigate how stress distributions correspond with tissue
markers related to plaque disruption. Therefore, we investigated the following specific aims:
2.3 Aim 1: Solid Mechanical Modeling of Plaque Rupture in Mice
Determine the distribution of stresses in the walls of murine atherosclerotic lesions under physio-
logical conditions and relate this to likelihood of rupture.
We proposed to answer the question: Is there a biomechanical explanation for the lack of ob-
served plaque rupture in murine atherosclerotic lesions? Plaque rupture in mice is a controversial
topic, with published claims of spontaneous plaque rupture in mice disputed by other researchers.
Using FEA to reconstruct the solid mechanical environment of mouse plaques, we attempted to
determine how the relative distribution of stresses compares to that in human plaques. We also
examined how morphological features like plaque shape and composition differ between mice and
humans.
The specific hypothesis was: The composition and shape of plaques in mice is characteristically
different from that in humans, which leads to a unique distribution of mechanical stresses between
species.
To study this, we computationally studied histological cross-sections of “vulnerable” plaques
from humans and mice. We analyzed the relative composition of the lesions, as well as the size and
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shape of morphological features like the extent of lipid and the relative thickness of fibrous caps.
We also computed the relative distribution of mechanical stresses to examine the location of local
maxima of Von Mises stresses.
2.4 Aim 2: Role of Inflammation and Solid Mechanics in Plaque Rupture and Plaque
Erosion
Investigate the distribution of mechanical stresses within vessel walls and on the plaque cap in
plaque erosion and plaque rupture specimens.
We proposed to answer the question: Can the difference in phenotypes between vulnerable and
disrupted human plaques be explained by solid biomechanics? Plaque rupture has been well estab-
lished as a phenomenon with both biological and solid mechanical causes. Plaque erosion, which
has only been described recently, is thought to have biological causes. Whether solid mechanics
plays a role as well is uncertain, as very little consideration of the subject has been published to
date. Using FEA to calculate the relative distribution of Von Mises stresses in eroded, ruptured,
“vulnerable”, and stable human plaques, we investigated characteristic differences in the mechani-
cal environments between the phenotypes. We also investigated if markers of proteins and biological
processes spatially correlate with mechanical stresses, suggesting a possible mechanism for induc-
tion of the different plaque disruption phenomena.
The specific hypothesis was: Solid mechanical stresses and strains in the vessel wall are associ-
ated with inflammatory markers in plaque rupture but not in plaque erosion.
To study this, we obtained consecutive serial cross-sections of human coronary atherosclerotic
plaques identified to have experienced plaque rupture or plaque erosion, or stable plaques charac-
terized as thin- or thick-cap fibroatheromas. We stained one section for gross morphology using
Movat’s pentachrome, which we used to identify the different tissue types as input for our lesion-
specific FEA computer model. We then stained serial sections for a variety of markers thought
related to inflammatory and remodeling processes to seek possible correlation between mechanical
stresses and expression of these markers.
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2.5 Aim 3: Computational Fluid Dynamics Simulations of Flow in Plaque Erosion
Examine the local hemodynamic environment around plaques that demonstrate pathological fea-
tures of erosion.
We proposed to answer the question: Can the occurrence of erosion in human plaques be ex-
plained by hemodynamics? WSS has been studied extensively and is known to play a major role
in atherogenesis. Several case studies have suggested that WSS may also have consequences for
plaque rupture, but no similar role of WSS in plaque erosion has been studied to date. Plaque ero-
sion may result from endothelial denudation, although the mechanism of endothelial cell loss in
these patients is not known. One possible pathway for endothelial damage is through very high
magnitudes of WSS. Given that plaque erosion is more prevalent in women and young men, and
that women on average have smaller diameters of coronary arteries than men, flow is one possible
explanation for induction of plaque erosion.
Therefore, our hypothesis was: Patients with plaque erosion will experience locally elevated
WSS magnitude in regions where erosion has occurred.
We reconstructed coronary arteries of human patients in the Emory University catheterization
lab with plaque rupture, plaque erosion, and stable plaques in order to compute the flow environment
within these vessels. 3D reconstructions were made from biplane angiogram images of human
coronary arteries confirmed to exhibit plaque erosion by OCT. We used CFD to calculate flow
metrics like WSS and OSI to investigate an association between flow features and thrombus location
in plaque erosion.
2.6 Significance and innovation
Although atherosclerotic mouse models are widely studied, debate continues about whether mice
can experience spontaneous plaque rupture. The goal of this model system is typically to recapitu-
late human physiological processes, but without widely-accepted evidence that plaques can sponta-
neously rupture, the mouse model is limited in its utility for studying plaque endpoints. Researchers
frequently speak about a “vulnerable” phenotype of plaques in mice, but without evidence of sponta-
neous plaque rupture, this term incorrectly implies that mouse plaques are more or less stable under
certain conditions. In this research, we examined the relative distribution of mechanical stresses in
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murine plaques to better understand their propensity for spontaneous plaque rupture. Other groups
have previously published studies of murine plaque mechanics, but ours considers a wider spectrum
of acute and chronic models of atherosclerosis than prior work. We also directly compare mouse
plaques to human plaques in order to draw conclusions about characteristic differences in plaque
mechanics between the organisms. This study will help researchers to better understand how mice
and men differ and discern whether using terms like “vulnerable plaques” to describe lesions in
mice is appropriate.
Plaque erosion is a more recently-discovered phenomenon whose cause is not well understood.
The role of solid and fluid mechanics in plaque rupture has been studied widely, but to date, almost
no mechanical analysis has been performed on plaque rupture specimens. Our existing knowledge
on plaque rupture is almost entirely biological. This research presents some of the first fluid and
solid mechanical analysis of human coronary arteries that experienced plaque erosion and compares
them directly to tissues that experienced plaque rupture as well as thin- and thick-cap fibroatheromas
that are not disrupted. The goal of this analysis is a better understanding of the mechanism of plaque
rupture and plaque erosion, which could eventually lead to improved diagnosis and even possible
treatment before these events have led to fatality.
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CHAPTER III
SOLID MECHANICAL MODELING OF PLAQUE RUPTURE IN MICE
Adapted from “Biomechanical Modeling and Morphology Analysis Indicates Plaque Rupture Due
to Mechanical Failure Unlikely in Atherosclerosis-Prone Mice” by Ian C. Campbell, Daiana Weiss,
Jonathan D. Suever, Renu Virmani, Alessandro Veneziani, Raymond P. Vito, John N. Oshinski, W.
Robert Taylor. Am J Physiol Heart Circ (in press, Epub November 30, 2012).
3.1 Introduction
Plaque rupture is a major cause of atherosclerosis-related thrombosis in the modern world that, de-
spite concerted research efforts, still is not fully understood. Most knowledge of plaque rupture
in humans comes from histological evaluation of autopsy specimens or from in vivo imaging of
high-risk patients after plaque rupture has already occurred; neither technique has led to direct ob-
servation of plaque rupture in progress. Therefore, scientists are forced to study the etiology of
plaque rupture either retrospectively in patients who already had a lesion rupture or prospectively in
patients who may or may not provide evidence of rupture at a later date. Extensive morphological
studies of histology specimens and mathematical modeling of biomechanics have led to identifica-
tion of the thin-cap fibroatheroma (TCFA) as the atherosclerotic plaque phenotype currently thought
to be most “vulnerable” to rupture [17].
Despite identification of this phenotype, it is still not possible to accurately predict rupture. Be-
cause longitudinal studies to identify rupture are impractical in humans, scientists frequently study
atherosclerosis-prone mice, which are known to rapidly and reliably form atherosclerotic plaques
over a period of weeks to months instead of years to decades, as is the case in humans. Rodents are
naturally resistant to atherosclerosis, but a wide variety of techniques for inducing atherosclerosis
exist [66]. As the mechanism behind each of these techniques is unique, the severity and specific
characteristics of the atherosclerotic burden varies among models [66]. Among the factors mod-
ulated by researchers are transgenic strain (with the ApoE-/- and LDLr-/- being the most popular),
diet (especially lipid composition), age, gender, and pharmaceutical agents (e.g. angiotensin II).
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Angiotensin II induces hypertension, which is a common comorbidity of atherosclerosis in humans.
However, much of the effect of angiotensin II on the vessel wall is proinflammatory [118]. Anatomic
location of the plaque is another variable, as the brachiocephalic artery has been reported to produce
lesions with some similarities to human “vulnerable” plaques [119]. Regardless of which permuta-
tion of conditions any particular research group uses, the overall goal is the same: to recapitulate
features of human atherosclerosis in a mouse model to better understand the pathophysiology of the
disease and, eventually, to develop treatments for its prevention and management.
In addition to the need for a robust animal model of atherosclerotic plaque formation, re-
searchers desire a relevant animal model for the study of thrombotic endpoints such as plaque
rupture. However, spontaneous plaque rupture in mice is a controversial topic [5–7, 73, 120, 121].
Several published reports of murine plaque rupture exist [122, 123], but others question whether
plaque rupture is really occurring in mice, suggesting that reports may actually be sectioning arti-
fact, intraplaque hemorrhage, or a completely different form of lesion disruption not seen in human
plaques [6]. Bond and Jackson, who developed a putative mouse model of plaque rupture, con-
test these claims and suggest that a mouse model need not be morphologically identical to human
plaques in order to be useful [77]. Many publications discuss “ruptured” and “vulnerable” plaques
in mice, although a unifying definition of the phenomenon does not exist. Schwartz and colleagues
have argued that, because the topic is so controversial, researchers avoid using the terms “vulnera-
ble” and “stable” to describe phenotypes of murine plaques until the community better understands
plaque disruption in mice [6].
Within this context, it is prudent to evaluate the morphological and mechanical stress differences
between mouse and human plaques. In the existing literature, several morphological risk factors
for human plaque rupture exist. The most well-known of such parameters is the thickness of the
fibrous cap overlying a necrotic core, but others such as the size and shape of the necrotic core and
the presence of microcalcifications embedded in the fibrous cap are emerging as well [23]. The
functional consequence of these features is that a concentration of mechanical stress occurs on the
fibrous cap or shoulders of the plaque, and if the magnitude of the stress is sufficient, the lesion will
rupture [105]. Biological factors such as inflammation are closely associated with plaque rupture
as well, but the final failure is, by definition, a physical, mechanical event. However, little is known
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about whether these geometric and mechanical risk factors translate to mice. Histological inspection
of murine plaques reveals distinct morphological differences from human atherosclerotic lesions,
the most obvious of which is size: a mouse aorta’s diameter is only a fraction of the diameter of a
human coronary artery.
In this study, we set out to quantify the morphological and mechanical phenotypes across a
range of mouse models. In order to consider the extremes of atherosclerosis-prone mice, on one
end of the spectrum, we investigated a chronic, more intrinsic model of atherogenesis, and on the
other end we equipped two popular strains of mice with an aggressive set of provocative factors
for acute atherosclerosis. Here, we provide a side-by-side quantification of the morphological and
mechanical stress distribution differences between mouse and human plaques. We hypothesized
that the plaque extent and composition would be significantly different between mouse and human
plaques. We further hypothesized that the relative distribution of locations of peak mechanical stress
characteristically found in mice is different from that found in human atherosclerotic lesions.
3.2 Methods
3.2.1 Mouse models
We considered three models of advanced atherosclerosis in mice, two of which acutely form plaques,
and the other was a chronic model. The first acute model included 15 male ApoE-/- mice aged 8
weeks fed a high-fat (HF) diet (D12336, Research Diets, Inc.) for 8 additional weeks with simul-
taneous subcutaneous infusion of Angiotensin II (AngII) via osmotic minipump (0.75 mg/kg/day,
Sigma Aldrich). The second acute model included 12 male LDLr-/- mice aged 8 weeks fed a HF diet
for 8 additional weeks with AngII via minipump [69,70]. The chronic model of spontaneous lesion
formation included 12 male ApoE-/- mice fed a regular chow diet (LabDiet 5001 Rodent Diet, PMI)
for 1 year without AngII. All animal research was approved by the Emory University Institutional
Animal Care and Use Committee (IACUC).
3.2.2 Tissue harvest
One day preceding harvest, each animal’s systolic blood pressure was recorded via tail-cuff mea-
surement (BP-2000, Visitech Systems). Animals were harvested using humane euthanasia tech-
niques (slow inhalation of CO2). Upon expiration, animals were perfused with saline followed by
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10% buffered formalin for 5 minutes at 80 mmHg (approximate diastolic blood pressure) by direct
cardiac injection. Then, to preserve the conformation of the lumen as closely as possible, mice were
then perfused with Batson’s #17 Vascular Casting Compound (Polysciences) at each mouse’s dias-
tolic blood pressure (assumed to be 40 mmHg below the mouse’s measured systolic blood pressure)
in order to preserve the in vivo conformation of the lumen. Pressure was maintained using an IV
pressure infuser (Infu-Surg, Ethox) and measured with an inline manometer. Upon hardening of the
vascular casting compound, the aortic tree between the heart and the descending thoracic aorta was
excised, fixed 48 hours in formalin, and then transferred to 70% ethanol.
3.2.3 Human specimens
Human coronary artery plaques of thin-cap fibroatheroma (TCFA) phenotype were selected from
an existing tissue bank by an expert in cardiovascular pathology (Renu Virmani, CVPath Institute).
Specimens were obtained as part of a consultation service for the Office of the Chief Medical Ex-
aminer of the State of Maryland. Fresh hearts were perfused with 10% neutral-buffered formalin at
100 mmHg for 15 minutes, and then the coronary arteries were excised and further fixed in formalin
before embedding.
3.2.4 Histology and microscopy
Murine aortic specimens were embedded in methyl methacrylate (MMA) resin then sectioned at 5
µm using an automated rotary microtome. Consecutive serial sections were obtained at the brachio-
cephalic artery immediately distal to bifurcation from the arch and at three sites in the descending
thoracic aorta each separated by approximately 1 cm. Tissues were deplasticized and stained to
identify plaque morphology using a hybrid Masson’s trichrome and Von Kossa’s calcium staining
technique [56]. Human specimens were embedded in paraffin, sectioned at 5 µm, and then stained
with Movat’s pentachrome. To ensure that the difference in stains between humans and mice did not
bias our evaluation of the morphology, we stained 9 mouse sections (3 per phenotype) with Movat’s
pentachrome. Images of all stained slides were obtained via brightfield microscopy. Sections with
major sectioning artifact were discarded.
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Figure 3.1: Semi-automated segmentation of atherosclerotic lesions: A sample cross-section of an
atherosclerotic LDLr-/- mouse aorta stained with a combination of Masson’s trichrome and Von
Kossa’s calcium stain. The microscopy image (left) was loaded into custom Matlab software and
segmented (right) using a semi-automated algorithm. In brief, tissue types were automatically iden-
tified using a k-means clustering algorithm and then touched up (for example, to distinguish lipid
from background) using an implementation of the Live Wire algorithm [125]. Perimeter of the
lumen and adventitia were also identified with Live Wire (red line).
3.2.5 Image segmentation
We classified the tissue of atherosclerotic blood vessels into four primary components [56]: cellular
tissue (primarily media), fibrous tissue, lipid, and calcification (Figure 3.1). Images were imported
into custom image analysis software implemented in Matlab (R2011b) and segmented using k-
means clustering based on staining color [124]. Manual revision, when necessary, was performed
using an implementation of the Live Wire edge-detection algorithm [125].
3.2.6 Morphological analysis
We measured four morphological parameters and one histological parameter in our microscopy
images using Matlab, shown in Figure 3.2. In brief, we traced the internal elastic lamina (IEL),
external elastic lamina (EEL), and lumen border in all images. A method for accurately measuring
tissue thickness developed by Yezzi et al. was used to compute the distance between any two
contours [126], and the radius of each vessel was defined as the radius of the minimum bounding
circle around the EEL. We calculated:
1. lesion coverage of the wall (defined as the fractional portion of the circumference of the vessel
where the thickness between the IEL and lumen was non-zero)
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2. plaque burden (the percent of the area inside the IEL containing lesion)
3. normalized mean lesion thickness, a measure of how far plaques protrude into the lumen
(defined as the distance between the IEL and the lumen only where non-zero, normalized to
media thickness, defined as the distance between the IEL and EEL)
4. normalized lesion eccentricity (the distance between the centroid of the lumen border contour
and the EEL contour, normalized to vessel radius)
5. relative composition of the lesion based upon the segmented image (the lesion was defined as
any tissue between the IEL and the lumen contour).
The statistical differences between models were computed by one-way ANOVA followed by
Tukey’s honestly significant difference test, with α=0.05. Results are shown in Figures 3.6 and 3.7,
and statistics are tabulated in Table 3.1.
3.2.7 Computational solid mechanics
We computed the relative distribution of stresses in each segmented vessel using an established
lesion-specific computational mechanical modeling technique in Ansys 13.0 APDL software [56].
We used a 2D plane strain large deformation finite element model. The cross-sectional shape of each
lesion was imported into Ansys and finely meshed with tens of thousands of elements. Based upon
image segmentation, linear elastic isotropic material properties were calculated for each element
using a constrained rule-of-mixtures approach [100,101]. We then simulated a pressure of 40 mmHg
(representing the incremental pressure of the pulse from diastole to systole) normal to the lumen
surface and calculated the relative distribution of Von Mises stress (Figure 3.3).
Our computational model is based upon an existing technique that we selected because of its
ability to use high-resolution histology imagery to generate lesion-specific relative stress distri-
butions [56]. Because model geometry is based upon tissue data pressure-fixed in its diastolic
conformation, we are able to recreate the mechanical environment of the vessel resulting from the
incremental pressure of each cardiac pulse. The downside to this technique is that, because the
tissue is embedded for histology, we cannot derive residual stresses and therefore cannot compute
exact stress magnitudes. As the deformations considered in our model are small compared to those
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Figure 3.2: Measurement of morphological parameters from histology: Lesion coverage of wall (a)
was defined as the percent of the vessel circumference with nonzero thickness between the internal
elastic lamina (IEL) and the lumen border. Plaque burden (b) was defined as the percent of the area
inside the IEL occupied by the lesion. Mean lesion thickness (c) was defined as the mean thickness
of the lesion normalized to the mean thickness of the media [126]. Eccentricity (d) was defined as
the distance between the centroid of the lumen border and the centroid of the IEL border, normalized
to vessel radius.
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Figure 3.3: Computer model of stress distributions in plaques: We harvested atherosclerotic plaques
from three different mouse models (top three rows) and obtained thin-cap fibroatheroma (TCFA)
specimens from human coronary arteries (bottom row). Using finite element analysis techniques,
we computed the distribution of solid mechanical stresses in each vessel cross-section. Local max-
ima of stress (red arrows) indicate that in mice, highest stresses are on the media and adventitia,
particularly on plaque-free walls, whereas in humans, local maxima tend to be on the thin fibrous
cap or shoulders of plaques. Tukey’s honestly significant difference test results are noted for com-
parisons of brachiocephalic aorta vs. human coronary and all descending aortae pooled together vs.
human coronary.
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resulting from initial pressurization of the vessel, the relative distribution of stresses should be min-
imally affected by this missing pre-stress data. The relative distribution of stresses provides insight
into the lack of plaque rupture in mice, and no published data on the stress magnitudes necessary to
cause plaque rupture in mice exists, anyway.
Our model took advantage of several theoretical simplifications to exploit the properties of the
system. Biological tissues are nonlinear, viscoelastic materials which are complex to represent
theoretically [12]. However, because material properties are known to be approximately bilinear
and because we only simulated the pressure range between diastolic and systolic blood pressure,
material properties for each tissue component could be represented with a linear elastic modulus
[100]. Higher order hyperelastic models, commonly used in simulations computing exact stress
magnitudes, are inappropriate for our scenario because data on the unloaded vessel is unavailable to
us.
For each element of the mesh, we applied linear elastic material properties based upon a con-
strained rule-of-mixtures approach [100, 101]. Mechanical properties for each of the four primary
tissue components were derived by Beattie et al. [22]: lipid: 3.88 × 105 dynes/cm2, cellular:
2.45×106 dynes/cm2, fibrous: 1.82×107 dynes/cm2, calcified: 1.07×108 dynes/cm2. Based upon
our segmented histology, we overlaid a fine-resolution mesh generated by Ansys software based
upon the contours of the lumen and outer edge of the adventitia. For each element of the mesh, the
rule-of-mixtures approach dictates that the effective elastic modulus is equal to the weighted aver-
age of the elastic moduli of tissue components present in that element. As the mesh was extremely
fine, the majority of elements represented only a single tissue type.
Additionally, biological tissues have been shown to exhibit anisotropy, particularly along fiber
directions [101]. Unfortunately, the atherosclerotic lesions that we are simulating are extraordinar-
ily complex and protrude non-uniformly into the lumen. Without information on the specific fiber
directions within the lesion, anisotropy is nearly impossible to model correctly, particularly in the
traditional cylindrical coordinate system by which most anisotropic material properties in the lit-
erature are described. The cross-sections of the blood vessels in our study are only approximately
circular, and therefore a polar coordinate system cannot be easily adopted.
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3.2.8 Computational mechanical loading conditions
In our model, we simulated an incremental pressure of 40 mmHg normal to the lumen, equal to the
difference in pressure between tissue fixed at 80 mmHg and a typical systolic blood pressure of 120
mmHg. Because the nonlinear material properties of arterial tissue are roughly bilinear, large de-
formations occur below 80 mmHg that yield very little stress [100]. Above the breakpoint in these
bilinear material properties, minimal deformation occurs but large stresses accumulate. Thus, by
fixing our tissue at 80 mmHg, we underestimate the overall magnitude of stress but input optimal
starting geometry. Since the stress-strain relation is approximately linear in this region, simulat-
ing higher magnitudes of stress (for example, simulating an incremental pressure of 120 mmHg)
will primarily affect the local stress magnitudes rather than distribution. Because we only consid-
ered stress distribution and not exact magnitudes in this study, we have minimized the limitation
of missing patient-specific incremental stresses. Calculation of exact magnitudes of stress requires
knowledge of residual stress as well as wall stresses from pressures below diastolic blood pressure.
Estimation of residual stress requires destructive measurements of tissue, impossible for our banked
dataset. Estimation of wall stresses from pressures below diastole is possible with inverse method
techniques, but the relative contribution of these stresses is expected to be small based upon the ap-
proximately bilinear stress-strain relationship for these tissues. We can approximate the distribution
of stresses in the wall from pulsatile blood pressure but not the exact magnitudes, which is why we
only consider the relative distribution of stresses in the present study.
To overcome morphological distortion in the human specimens, cross-sections were digitally
pre-inflated. This technique resulted in more circular lumens as would be found in vivo and elim-
inated stress and strain concentrations at sites of steep bending not associated with features of the
plaque, presumed to be tissue processing artifacts. After 10 iterations of this pre-inflation technique,
stress and strain concentrations at sites of presumed histology artifacts disappeared, but stress and
strain concentrations located at sites associated with plaque morphology (on the thin fibrous cap,
plaque shoulders near the lipid core, etc.) remained. Sensitivity analysis revealed that results were
unaffected after about 10 pre-inflation iterations.
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3.2.9 Postprocessing analysis
We examined the relative distribution of stresses by mapping sites of highest stress by plotting
each Von Mises stress distribution in Tecplot 360 software. We displayed stresses greater than
a threshold value, defined as the vessel’s mean stress + 4 standard deviations. The locations of
stresses greater than this threshold were tallied based upon their location (Figure 3.4): fibrous cap
over lipid core, shoulder of plaque, elsewhere on or in plaque other than fibrous cap over lipid core,
or on media/adventitia. Media was defined as a circular ring staining positively for cellular tissue
(red in Masson’s trichrome), and adventitia was defined as all contiguous tissue outside the EEL.
Contiguous tissue between the IEL and the lumen was considered plaque, with fibrous cap over
lipid core specifically defined as fibrous tissue (blue in Masson’s Trichrome) forming a thin strip
separating lumen from lipid. Plaque shoulder was defined as the zone where fibrous or cellular
tissue of a plaque meets the media at the periphery of the plaque. For each section, we quantified
the location of stress peaks, recording a binary tally for the presence of a local maximum of stress
in each region of each section. Some sections had multiple local maxima but were only counted
once per location per section: for example, a plaque with one local maximum on the shoulder of
the plaque and two distinct peaks in the media would receive one tally for the shoulder and one
for the media. The threshold of 4 standard deviations was determined empirically as the highest
integer multiple of the standard deviation that identified at least one local maximum per section.
To ensure that our choice of stains (Masson’s trichrome and Von Kossa’s calcium in mice and
Movat’s pentachrome in humans) did not affect our stress analysis, we performed identical analysis
on consecutive serial section pairs stained with both protocols and confirmed that the tallies of local
maxima of stress were exactly identical (Figure 3.5).
3.2.10 Plaque cap thickness analysis
In only the subset of lesions exhibiting a local maximum of stress located on a fibrous cap over
lipid-rich core, we computed the thickness of the fibrous cap at the site of peak stress relative to
the mean thickness of the media around the entire vessel [126]. Differences between groups were
assessed using an unpaired, two-tailed t-test with α=0.05 and Bonferroni correction for multiple
comparisons.
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Figure 3.4: Annotation of locations: We identified the location of local maxima of Von Mises
stresses (Figure 3.3) according to several anatomic criteria, denoted here. Peak stresses were either
identified as being located on a thin fibrous cap over a lipid-rich core or plaque shoulders, the two
locations where plaque rupture are known to occur in human lesions, or on the media or adventitia
or elsewhere in the plaque. Tukey’s honestly significant difference test results are noted for com-
parisons of brachiocephalic aorta vs. human coronary and all descending aortae pooled together vs.
human coronary.
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Figure 3.5: Validation of staining protocols: We stained consecutive serial sections of mouse tissue
with Masson’s Trichrome and Von Kossa’s calcium protocols (top) and with Movat’s Pentachrome
protocol (bottom). Here, representative images paired with their segmentation demonstrate quali-
tative agreement. The location of local maxima of stress (not shown) did not differ between spec-
imens. Only tissue inside the lines marked “vessel border” was included in our study, so periad-
ventitial segmentation differences will not affect results. A representative problem with the Movat’s
pentachrome stain in our tissues is visible in the LDLr-/- and older ApoE-/- specimens: the vascular
casting compound absorbed dye, partially obscuring nearby tissue.
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3.2.11 Calcification analysis
To assess of the presence of microcalcifications, we scanned the brachiocephalic arteries and de-
scending aortas of a subset of our mice (3 LDLr-/- fed HF diet for 8 weeks with AngII and 3 ApoE-/-
fed regular diet for 1 year) using microCT (µCT 50, Scanco Medical, Brttisellen, Switzerland).
Tissues were scanned in 70% ethanol. A positive control scan of hydroxyapatite powder (Fisher
Scientific) was analyzed with scanning electron microscopy (DS-130F, Topcon Positioning Sys-
tems, Livermore, CA) to determine its particle size. This powder was then scanned with microCT
to confirm the equipment’s ability to resolve microcalcifications. Additionally, adjacent sections of
the ascending aorta were stained with alizarin red to further confirm the presence of calcium.
3.3 Results
We computed morphological metrics and relative stress distributions in plaques without significant
sectioning artifacts from mice without premature mortality. In total, we evaluated plaques from 10
young ApoE-/- mice, 11 young LDLr-/- mice, and 11 old ApoE-/- mice. Mortality was highest for
the group of young ApoE-/- mice, with 10 mice expiring within 10 weeks. This animal model has
previously been reported to experience aortic aneurysms and dissection at approximately this rate
[70,127]. One LDLr-/- mouse expired prematurely, and one older ApoE-/- developed dermatitis and
was sacrificed. We evaluated brachiocephalic, proximal descending thoracic aorta, mid descending
thoracic aorta, and distal descending thoracic aorta plaques totaling 34 sections in young ApoE-/-
mice, 42 sections in young LDLr-/- mice, and 49 sections in old ApoE-/- mice. In humans, we
evaluated 11 coronary plaque sections.
3.3.1 Morphology Analysis
In all four morphological metrics we examined, atherosclerotic plaques from each of the three
mouse models were significantly smaller than human lesions. Murine lesions covered less of the
wall, plaque burden was lower, the normalized mean lesion thickness was lower, and the normalized
eccentricity of plaques was lower. Results are shown in Figure 3.6, and statistics are tabulated in
Table 3.1. In all mouse models, the brachiocephalic artery had greater plaque burden, normalized
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Figure 3.6: Morphological measures of murine and human plaques: Geometric features of
atherosclerotic plaques were measured from histology specimens of lesions from humans and mice.
Error bars represent standard error.
considered, and the difference sites in the descending aorta were mostly not different from one an-
other. In the chronic model of plaque formation, the brachiocephalic artery lesions covered a greater
fraction of the wall than the descending aorta plaques, but this trend was not observed in either of
the acute models.
The relative composition of human plaques was different from murine plaques, as well. Human
plaques were, on average, significantly more fibrotic and calcified and contained less cellular tissue
than mouse plaques. The foam cell/necrotic core content was significantly higher in young mice
than in humans, but our chronic ApoE-/- mouse model was not significantly different in lipid content
than human coronary plaques. Differences are shown in Figure 3.7, and statistics are tabulated in
Table 3.1.
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Table 3.1: Statistical results from Tukey’s honestly significant difference post hoc test for mor-
phological metrics. P-values are shown for comparisons among the following groups: yA: young
ApoE-/-, yL: young LDLr-/-, oA: old ApoE-/-, H: human
Metric yA v yL yA v oA yL v oA yA v H yL v H oA v H
Percent of wall
covered with lesion 0.29219 < 0.00001 0.00010 0.00198 0.00001 < 0.00001
Plaque burden 0.97702 0.14574 0.27482 < 0.00001 < 0.00001 < 0.00001
Lesion thickness 0.19357 0.99999 0.14242 < 0.00001 < 0.00001 < 0.00001
Eccentricity 0.95805 0.98027 0.77581 0.09288 0.17335 0.04070
% Fibrous 0.11130 0.00146 < 0.00001 < 0.00001 < 0.00001 0.00445
% Lipid 0.00036 0.00138 < 0.00001 0.08164 < 0.00001 0.99999
% Cellular 0.30812 0.99999 0.25562 0.00044 0.01725 0.00029
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Figure 3.7: Relative composition of atherosclerotic plaques in mice and humans: Based upon seg-
mented atherosclerotic plaques (Figure 3.1), we calculated the relative composition of lesions for
humans and mice. Error bars represent standard error.
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Table 3.2: Tally of stress concentration locations
Fib. Cap Shoulder
Total Over Lipid of Inside Media or
Sections Core Plaque Plaque Adv.
ApoE-/- (8 wk HF, AngII) 34 4 2 7 34
Brachiocephalic 9 0 2 3 9
Proximal Descending 9 1 0 2 9
Medial Descending 10 2 0 1 10
Distal Descending 6 1 0 1 6
LDLr-/- (8 wk HF, AngII) 42 4 0 5 42
Brachiocephalic 11 0 0 2 11
Proximal Descending 10 0 0 3 10
Medial Descending 10 0 0 0 10
Distal Descending 11 4 0 0 11
ApoE-/- (1 yr reg chow) 49 0 2 7 49
Brachiocephalic 8 0 1 3 8
Proximal Descending 11 0 0 1 11
Medial Descending 10 0 0 0 10
Distal Descending 20 0 1 3 20
Total Mice 125 8 4 19 125
Brachiocephalic 28 0 3 8 28
Proximal Descending 30 1 0 6 30
Medial Descending 30 2 0 1 30
Distal Descending 37 5 1 4 37
Human TCFA 11 10 1 2 4
3.3.2 Mechanical Analysis
In mice, only 8 of 125 (6.4%) sections had high stress regions on a thin fibrous cap over a lipid
core, while all 125 of 125 (100%) plaques examined had regions of peak stresses located in the
media and adventitia. All lesions with local maxima of stress on the fibrous cap were located in the
descending aorta, not the brachiocephalic artery. Four of 125 (3.2%) lesions had stress peaks on the
plaque shoulder, most of which were in the brachiocephalic artery, and 19 of 125 (15.2%) had stress
peaks inside the plaque. By contrast, in humans, 10 of 11 (90.9%) of plaques had regions of peak
stress on the thin fibrous cap over a lipid core, and the 1 section without a peak stress region on the
fibrous cap exhibited a concentration of stress on the plaque shoulder (9.1% of 11 lesions). 4 of 11
(36.4%) of regions of stress peaks were on the media or adventitia, and 2 of 11 (18.2%) had a local
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Locations of Local Maxima of Stress 



















Figure 3.8: Locations of local maxima of stress: After computational solid mechanical modeling
of Von Mises stress distributions in atherosclerotic plaques, we quantified the percentage of vessels
exhibiting local maxima of stress in specific locations. A local maximum was defined as stresses
greater than 4 standard deviations above the vessel’s mean stress. Very few mouse vessels exhibited
peak stresses in a fibrous cap over lipid-rich core, whereas nearly all human thin-cap fibroatheromas
(TCFA) did. By contrast, every single mouse vessel had peak stress in the adventitia or media,
whereas less than half of human plaques did. Mice were fed high-fat (HF) or regular chow (reg.
chow) diets, and some mice received Angiotensin II (AngII). Above each bar is the raw number of
vessels with a local maximum at the specified location.
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3.3.3 Fibrous Caps
The relative thickness of murine lesions experiencing a stress peak on the fibrous cap was higher
or indistinguishable from that in humans. In young ApoE-/- mice, the mean relative thickness (ratio
of fibrous cap thickness at site of peak stress to mean media thickness) was 0.842 ± 0.105 (n=4
mice with local maximum stress on fibrous cap, mean ± SEM cap thickness: 29.8 ± 4.0 µm, media
thickness: 35.3 ± 1.0 µm), in young LDLr-/- mice, the mean ratio was 0.322 ± 0.056 (n=4, mean
± SEM cap thickness: 11.8 ± 1.9 µm, media thickness: 37.2 ± 1.4 µm), and in human coronary
arteries the mean ratio was similar at 0.349 ± 0.025 (n=11, mean ± SEM cap thickness: 43.8 ± 2.4
µm, media thickness: 156.3 ± 7.3 µm). The difference in relative thicknesses between humans and
young ApoE-/- mice was significant (p=0.019), but between humans and young LDLr-/- mice was
not (p=0.867).
3.3.4 Micro and macrocalcifications
We observed histologically the presence of macrocalcifications in the brachiocephalic artery in our
chronic model of plaque formation, the ApoE-/- mouse aged one year on a regular chow diet (Figure
3.9). We did not observe similar macrocalcifications in either of our 8-week mouse models. Putative
microcalcifications, by contrast, were observed in all three mouse models with both Von Kossa and
alizarin red stains (Figure 3.10). In our histological examination of the ascending aortas in our mice,
we observed punctate positive staining for calcium on the aortic valve leaflets.
In microCT analysis of our older ApoE-/- mice (chronic model), regions of radiodensity similar
to the hydroxyapatite powder (positive control) were present, including isolated voxels of positive
signal that would appear to be “microcalcifications” (Figure 3.11). Whether these were located
within the thin fibrous cap as proposed by Vengrenyuk et al. [113] cannot be discerned due to low
contrast between tissue and surrounding ethanol. Similar positive speckling was not observed in
any samples of the acute model we scanned.
3.4 Discussion
The major findings of this study are that the shape, size, and composition of atherosclerotic plaques
are different between mice and humans, and as a result, the relative distribution of solid mechanical
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Figure 3.9: Macrocalcification in the brachiocephalic artery of ApoE-/- mouse: Von Kossa’s calcium
stain was performed in conjunction with a modified protocol for Masson’s Trichrome, so black stain
is positive for calcification.
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Figure 3.10: Microcalcifications in the ascending aorta of mouse models: Microcalcifications are
visible in (left) ApoE-/- (8 wk HF diet, AngII), (middle) LDLr-/- (8 wk HF diet, AngII), and (right)
ApoE-/- (1 yr, regular chow diet) mouse models as confirmed by Von Kossa’s calcium stain (top
row) and alizarin red stain (bottom row).
Figure 3.11: MicroCT reveals calcifications in mouse artery: Small white speckles in this older
ApoE-/- mouse at the brachiocephalic bifurcation indicate the presence of calcium. The vessel wall
is very faint, so precisely identifying where inside the lesion these calcifications lie is difficult.
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stresses in mice does not result in local maxima on a thin fibrous cap over a lipid-rich necrotic
core, as is the case in humans. Therefore, our results demonstrate that atherosclerotic lesions in
mice and men have significant morphological and mechanical differences. Given the differences in
genes, vessel diameter, posture (which implicitly may affect the blood flow patterns that modulate
lesion progression), time course, and location of lesions, a distinction between mice and humans is
not unreasonable to expect. However, the consequences of these dissimilarities suggest that other
characteristics of lesions, such as propensity for plaque rupture, may be different as well. As a link
between lesion morphology and mechanical environment has been established, we felt that a direct
comparison of the mechanical differences between human and murine plaques was prudent [23].
Our mechanical analysis is based on an established technique for calculating the relative dis-
tribution of stresses from histology specimens [56]. We selected Von Mises stress as our metric
because it approximates the magnitude of the local stress tensor at any given point and because it
has been associated with inflammatory processes that may underlie the biological basis of plaque
rupture [56]. Here, we showed that the relative distribution of solid mechanical stresses in mice is
such that the highest stresses are on the media and adventitia rather than on the thin fibrous cap of
atherosclerotic lesions. By contrast, our results demonstrate that human plaques experience these
highest stresses on the fibrous cap or shoulders of the lesion, in line with current understanding of
the mechanics of plaque rupture [62]. The nature of our model is a relative analysis of the wall stress
distribution, so we have no way of knowing if these localized concentrations of high stresses are of
sufficient magnitude to disrupt the tissue. What the relative distribution of stresses can tell us, how-
ever, is that because stresses are highest on media and adventitia, these mice would be susceptible to
whole-vessel aortic or carotid rupture before any intra-plaque rupture resulting from lumenal blood
pressure might occur. Such catastrophic vessel bursting has not, to our knowledge, been reported in
these mouse models. Therefore, spontaneous plaque rupture, if it is possible in mice, seems unlikely
to be driven solely by the overall mechanical environment.
From a purely mechanical perspective, the fact that stresses are locally the highest on the thin,
plaque-free portions of the wall in mice is not unexpected. The punctate distribution of plaques
in mice, which in our models tended to be primarily focal, almost like lipid-rich growths adhered
to the surface of otherwise healthy media and adventitia, is a key difference between mouse and
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human lesions. The highly focal distribution of plaques in mice was especially noticeable at the
brachiocephalic bifurcation from the aortic arch, a site where many investigators have searched
for evidence of murine plaque rupture. Lesions in the brachiocephalic artery were always located
on the upstream side of the bifurcation (where low and oscillatory shear stress occur), while the
downstream wall never formed neointima [128]. Maximum stresses were distributed on the healthy,
thin wall and were of much lower magnitude within the lesion itself. Whereas in humans, some
amount of fibrotic neointimal hyperplasia is frequently observed on all portions of the wall (100%
of the human coronary lesions in this study had complete circumferential hyperplasia), our mouse
models did not recapitulate this feature of the lesions, which likely influences the distribution of
mechanical stresses.
The time scale of plaque formation may be a plausible explanation for this phenomenon. In
humans, plaques, particularly those of the TCFA phenotype, develop over a period of 40-70 years,
orders of magnitude longer than the lifespan of even our chronic mouse model of atherosclerosis.
In humans, this gradual plaque formation results in “Glagov remodeling” wherein lesions remodel
outward and preserve lumen diameter until the plaque burden has reached a certain threshold, at
which point the plaque begins to encroach upon the lumen [44]. In many of our mouse plaque
specimens, which were pressure-perfused with a vascular casting compound in an attempt to his-
tologically preserve the relative in vivo conformation of the vessel, we could closely circumscribe
a circle around the EEL (Figure 3.12). The circular media with lesions protruding into the lumen
suggests that Glagov remodeling may not be recapitulated in our mouse models, which is further
evidence that mouse plaques are morphologically and mechanically different from human plaques.
Another noteworthy morphological difference with mechanical implications between mice and
men is that of the fibrous cap. A current criterion for a TCFA in human arteries is a fibrous cap
thinner than 65 microns. In mice, whose vessels and plaques are much smaller than in humans,
almost every fibrous cap is below this threshold, and yet plaque rupture is certainly not as preva-
lent as in humans. Although peak stresses occasionally occurred on the surface of murine lesions
(6.4%), these almost never coincided with the presence of a thin fibrous cap over a lipid-rich region
of the plaque. In humans, current understanding of the mechanics of plaque rupture is that peak
stresses on the thin fibrous cap or its shoulders lead to tissue disruption [62]. Our mechanical model
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Figure 3.12: Glagov remodeling does not occur in some mouse plaques: The minimum bounding
circle circumscribed around the external elastic lamina (yellow line) in pressure-fixed mouse aortas
very closely approximates the geometry of the media. Atherosclerotic lesions in these vessels pro-
trude inward from the media into the lumen rather than remodeling outward to preserve the shape
and diameter of the lumen, in contrast with the Glagov theory of remodeling in humans [44].
recapitulated this finding, with 100% of human TCFA specimens demonstrating a local maximum
of stress on the fibrous cap or its shoulders. In mice, however, local stress concentrations did not
appear to be associated with the presence of a thin fibrous cap. We observed numerous thin fibrous
caps in mice without a local maximum of stress on that site, and the few stress concentrations we
observed that were adjacent to the lumen occurred on relatively “thick” caps. Additionally, none of
the murine plaques with superficial stress concentrations were brachiocephalic plaques, suggesting
that if spontaneous plaque rupture can occur in mice, this may not be the best candidate site. Buried
fibrous caps, which some have proposed are evidence of prior rupture that has healed, were present
in many of our murine specimens (for example, see Figure 3.3, upper left) [129]. Because histology
is simply a snapshot in time, we cannot comment on the history of these plaques beyond observing
that some buried fibrous caps are indeed present and that they did not seem to be host for local
maxima of stress, either.
In addition to differences between mice and humans, we observed differences in morphology
and composition among our mouse models. Fibrous caps experiencing a local maximum of stress
were different between our two young mouse models, with both the absolute and relative thickness
lower in LDLr-/- mice, perhaps due to a different rate of fibrotic processes. Plaques from LDLr-/-
mice contained more lipid and less fibrous tissue than either of their ApoE-/- counterparts, suggesting
that fibrotic processes may differ between these genetically distinct mice.
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Although we considered both acute and chronic models of plaque formation in mice, lesions
shared quantitative morphological similarities among all three models. For all four morphologi-
cal metrics we considered, brachiocephalic plaques were similar to other models’ brachiocephalic
plaques, and other than the amount of the wall covered by lesion, descending aortic plaques were
morpholologically similar to other models’ descending aortic plaques. In the descending aorta,
plaques in older ApoE-/- mice cover less of the wall than their younger counterparts. Considering
that some rupture studies investigate murine brachiocephalic plaques because of purported similar-
ity to human coronary plaques, the difference in magnitude of morphological metrics between mice
and humans is striking.
Calcification is another morphological feature potentially tied to plaque rupture [114]. That
we saw extensive calcification (Figure 3.9) only in our older mice and not in either of our 8-week
mouse models suggests that formation of macrocalcification only occurs on longer timescales (such
as that of humans, where plaques form over decades). We did not include the ascending aortas of
mice in our mechanical analysis because of the extra complication of modeling the valve leaflets
and because there is little evidence of purported plaque rupture in mice at this site, but there we
observed tiny, punctate calcifications (we avoid definitively calling them microcalcifications be-
cause no established definition of the phenomenon exists that can be applied to mice) with both
histology and microCT. In humans, valve calcification is regarded as a different pathophysiology as
atherosclerosis, so it is unclear if the presence of these tiny calcifications in both the valve leaflet
and around the lipid-laden cells on the leaflet are relevant for our understanding of plaque rupture.
We did include the effects of calcifications in our modeling technique, but we saw only evidence
of macrocalcifications in our particular sections. A recent study by Maldonado et al. observed mi-
crocalcifications in 9 of 92 specimens, so given our sample size of 11 human coronary arteries, the
absence of microcalcificiations is not unexpected [114].f
Our findings agree with and build upon previous studies investigating the solid mechanics of
murine blood vessels from Broisat et al. [130] and Vengrenyuk et al. [131]. Vengrenyuk et al.
investigated how fibrous cap thickness affected stress magnitude in ApoE-/- mouse plaques, although
the threshold magnitude for rupture to occur is not known [131]. More recently, Broisat et al.
studied the solid mechanics of brachiocephalic plaques in female ApoE-/- mice of varying ages
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and found that the distribution of solid mechanical stresses was not favorable for plaque rupture
to occur [130]. These prior studies provided initial evidence that spontaneous plaque rupture is
mechanically unlikely in mice and established a need for expanded evaluation of the solid mechanics
of commonly-studied atherosclerotic mouse models with direct comparisons to human plaques.
However, these prior studies did not use identical mechanical modeling or histological embed-
ding techniques, and thus it is difficult to compare results from the acute model of atherosclerosis
studied by Broisat et al. with the chronic model studied by Vengrenyuk et al. Because many as-
sumptions go into mechanical modeling, it is important to validate the findings against existing
knowledge, which is why we included human TCFA specimens in the present study. These other
studies calculated specific magnitudes of mechanical stresses, but we only focused on the relative
distribution of stresses because of the known limitations of our technique for calculating such quan-
tities.
Our study investigated both ends of the spectrum of atherosclerotic mouse models, both chronic
and acute, in a manner such that a range of murine plaque morphology and mechanics could be
compared to human coronary plaques. Although this is not a comprehensive investigation of all
possible permutations of atherosclerotic mouse models, it represents a telling cross-section of the
spectrum of mouse models. Our rationale for selecting such extreme models of lesion formation was
that if mice with the largest plaques don’t appear to experience spontaneous plaque rupture, rupture
seems even less likely in more moderate models. We considered a different set of animal models
than either previous study on mechanical modeling of murine plaques. We focused exclusively on
male mice since gender is known to affect plaque phenotype in mice as well as humans, and we
included hypertension, a common comorbidity of atherosclerosis [65, 69]. We included the LDLr-/-
strain, often studied but not previously considered in mechanical studies, and we considered plaques
from the descending thoracic aorta in addition to the brachiocephalic artery, a site not included in
previous analyses [66]. In this study, we considered all of these features in order to analyze a
different subset of mice and compare them directly to humans, and our results in both mice and in
humans are consistent with the findings of prior studies.
A recent study by Ohayon et al. investigated the role of species-specific material properties in
computational solid mechanical simulations [132]. They found that using human material properties
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in simulations of murine plaques led to an overestimation of stresses inside the plaque. Although
their mechanical modeling approach and geometry generation technique differed from ours, this
finding suggests that we may be overestimating the frequency of local maxima outside the media and
adventitia in mice shown in Figure 3.8. This strengthens our conclusion that the relative distribution
of stresses is fundamentally different between mice and humans.
It is interesting to note that lesion morphology was variable both between and within each of
our experimental groups. Even though we employed inbred mouse strains given identical treat-
ments to induce atherosclerosis, the exact extent, shape, and location of lesions varied from mouse
to mouse. In humans, the etiology of lesions was even more variable, since so many physiological
and lifestyle factors influence plaque formation. Therefore, we expect lesion-to-lesion variability
to be even higher in humans than in mice. Because we only harvested mice at 8 weeks and at 1
year, we do not have any data on intermediate phases of lesion development in these animals. Given
that we observed differences in fibrous tissue content between our three mouse models, it would be
interesting to harvest additional timepoints in future studies to track the progression of plaques from
immature to advanced phenotypes. Gross examination of murine cross-sections suggests that ad-
vanced lesions contain more complex morphology such as more internal fibrous bands sequestering
small, individual necrotic cores than in lesions from acute models. However, because lesion-to-
lesion variability is high and because lesion harvest requires euthanizing the animal, quantitative
assessment of these trends is complex.
One limitation to our current study is that our human and mouse tissues were histologically pre-
pared differently. Both our embedding and staining protocols differed because the tissues came from
different sources. Human coronary arteries were obtained from an existing tissue bank: already for-
malin fixed, paraffin-embedded, and stained with Movat’s pentachrome. This technique provides
high-quality preservation of vessel composition, but some morphological distortion occurs during
tissue processing and sectioning. To overcome such processing artifacts in our murine dataset, we
embedded tissue in MMA and perfused the lumen with a vascular casting compound. A conse-
quence of this technique is that Movat’s pentachrome staining is impossible: the vascular casting
compound, transparent in Masson’s trichrome staining, swells during Movat’s staining and absorbs
the black elastic/nuclear stain (visible in Figure 3.5). In many sections, it obscures the surrounding
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tissue, making analysis impossible. Rather than discard the majority of our murine dataset where
this occurred, we opted to stain with Masson’s trichrome after demonstrating that the stain did not
affect our mechanical analysis.
In order to ensure that our lesion-specific model was based upon accurate histology data, we de-
veloped a novel vessel harvesting technique that employs vascular casting and plastic resin embed-
ding to maximize the accuracy by which we capture lesion morphology in its in vivo conformation.
Even when a mouse aorta is formalin fixed under pressure, the vessel remains compliant and col-
lapses as soon as pressure is released, presenting a significant problem for investigators attempting
to preserve the lumen geometry. Failure to preserve the lumen in its circular in vivo conformation
will lead to calculation of high strains at sites where the vessel collapses, making it impossible to
distinguish the mechanics of the vessel from the mechanics of the histology artifact. By perfusing
our mice with vascular casting compound, we were able to minimize such artifact by preserving the
lumen in its pressurized, circular conformation.
A second consideration sometimes overlooked in histology-based models is the choice of em-
bedding medium. Although frozen and paraffin sections both offer high compatibility with commer-
cial antibodies for immunohistochemistry, both suffer from morphological distortion of the tissue
during sectioning, as the vessel stretches axially in the cutting direction. By embedding our tissues
in methyl methacrylate resin and then cutting with a motorized diamond blade microtome, we could
evenly apply pressure across the surface of the block to minimize sectioning artifacts. Additionally,
because of the stiffness of methyl methacrylate, we were able to cut calcified mouse plaques in many
cases with minimal shattering or shredding of neighboring tissue. Unfortunately, unlike frozen sec-
tions, the methyl methacrylate embedding process requires tissue dehydration through graded alco-
hols, so lipid (which shows as negative space in our sections) cannot be detected through stains like
Oil Red O.
In this study, we derived our material properties from published values of elastic moduli for
human coronary arteries. Recently, Tracqui et al. measured tissue-specific mechanical properties
for several components of atherosclerotic lesions in ApoE-/- mice, and these properties were used in
the publication of Broisat et al. [130, 133]. However, Tracqui did not publish values for the media
or for calcifications, which are essential components of our computational model, and Broisat used
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a hyperelastic model of the unloaded media that cannot be applied to our pressure-fixed tissue data.
Similarly, Hayenga et al. also measured material properties of murine atherosclerotic plaques but
also did not differentiate between the different components of plaque that we identified in our model
with histology [134]. Rather than arbitrarily selecting material properties for the missing compo-
nents from the literature, we decided to use an internally consistent dataset of material properties all
measured from identical atherosclerotic lesions. Although one might extrapolate that the material
properties of mouse plaques are different from humans’ based upon our results showing unique me-
chanical environments between organisms, we prioritized self-consistency of modeling parameters
over use of animal-specific properties in only a portion of the model. The relative stress distribution
is insensitive to small differences in elastic moduli as well as to large differences as long as the
relative order of magnitude of the tissue components remains constant, and the order of magnitude
between tissue components in our model is comparable to those measured by Tracqui [112]. Addi-
tionally, Ohayon et al. recently found that the use of human material properties to calculate murine
solid mechanics overestimates stresses inside of plaques [132]. Therefore, because we used human
material properties, our methods likely lead to overestimation of the frequency of local maxima of
stress in mice.
Preliminary modeling revealed that human tissues suffered from tissue processing artifacts,
likely related to paraffin embedding and sectioning. Von Mises stress and strain maps revealed
stress and strain concentrations at sites of morphological distortion in the original histology, such
as steeply-curved edges of the lumen. These concentrations were not located at sites related to the
composition of the plaque, such as at the edge of necrotic core or fibrous cap, and were instead at
seemingly random locations. Because these probably resulted from tissue distortion during embed-
ding and sectioning rather than from the innate biomechanics of human plaques, we “pre-inflated”
these plaques in our computer model by applying a pressure of 40 mmHg normal to the lumen, al-
lowing the tissue to deform, then remeshing and repeating the process for a total of 10 iterations. All
modeling protocols during the pre-inflation steps were identical to those used for the final inflation
step for human tissues as well as for mouse tissues (which were not pre-inflated because they did
not suffer from similar histology artifacts). Von Mises stress data from the 10th iteration was used
for our final analysis for human specimens. To ensure that pre-inflation was not affecting our final
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results, sensitivity analysis was performed. This demonstrated that stress and strain concentration
sites did not change after the 10th iteration and that the only sites that changed between the first and
10th iteration were those at sites of presumed tissue distortion.
Although our modeling technique determines only relative levels of stress, results are still useful
for understanding the mechanical environment in murine plaques. Additional steps, such as estima-
tion of initial stress or a full 3D reconstruction of the lesions, while elegant, would add considerable
complexity and carry their own set of assumptions and limitations. In this study, we isolated the
role of Von Mises stress in plaque rupture, although additional factors such as fluid shear stress
and hydrostatic pressure likely play a role. Here, we specifically wanted to investigate the role of
solid mechanics in plaque rupture. Our lesion-specific, histology-based analysis of the morphology
and mechanics of human and murine atherosclerotic plaques indicates that solid mechanics may
not predispose mice to plaque rupture in mice in the same way as they do in humans. Additional
morphological metrics could have been considered in addition to those included in this study, but
those we measured provide clear evidence that the relative shape and composition of murine lesions
are unique from human lesions.
In the literature, researchers not infrequently interpret plaque morphology in mice as a trans-
formation to a “more vulnerable phenotype”. Our results suggest that such terminology may be
inappropriate. Geometric risk factors for plaque rupture in humans such as thin fibrous caps and
large necrotic cores do not appear to be associated with a distribution of mechanical stresses likely
to cause rupture in the mouse models we examined. Certainly, spontaneous plaque rupture in mice
is controversial. This study suggests that, if spontaneous plaque rupture does occur in mice, then
unlike humans, it does so through a different mechanism than mechanics.
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CHAPTER IV
ROLE OF INFLAMMATION AND SOLID MECHANICS IN PLAQUE RUPTURE
AND PLAQUE EROSION
4.1 Introduction
Thrombotic occlusion of the coronary arteries, a leading cause of morbidity and mortality world-
wide, may be caused by a number of events. The most extensively studied phenomenon is plaque
rupture, in which an advanced fibroatheroma develops through inflammation-mediated mechanisms
and eventually fissures, exposing the blood to pro-thrombogenic necrotic core and resulting in
thrombus formation. More recently identified is a second major cause of sudden coronary death,
termed plaque erosion, where a thrombus forms that does not communicate with the necrotic core
of an atherosclerotic plaque. Plaque erosion occurs frequently: two studies found that 40% of fatal
coronary thrombi resulted from erosion [30, 34]. However, demographics with highest incidence
of plaque erosion differ from traditional candidates for rupture: plaque erosion tends to occur in
younger individuals, particularly women [17].
Despite identification of the plaque erosion phenomenon, its mechanism is not well understood.
The leading hypothesis for erosion (and its namesake) suggests that endothelial denudation over
an atherosclerotic plaque presents a thrombogenic substrate to the blood. The cause of this focal
denudation is not known, but possibilities including vasospasm and highly shearing flow have been
suggested [34]. Endothelial apoptosis leads to denudation in animal models [37, 135], but histo-
logical studies have shown that inflammatory cells like macrophages and lymphocytes prevalent in
ruptured plaques that may induce apoptosis are not as widespread in eroded plaques [36]. Therefore,
there is a need to better understand the factors leading to plaque erosion.
In addition to the biological mechanisms of inflammation and tissue remodeling, other factors
affecting the stability of plaques include mechanical stress and strain. The role of biomechanics in
plaque rupture is well established: a thin fibrous cap over a necrotic core usually has local maxima of
stress on the cap or the plaque shoulders, sites where rupture is known to occur [105]. Additionally,
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mechanosensitive tissue markers related to inflammation and the development of atherosclerosis
have been identified [56,57]. To date, no analysis has focused on the role of biomechanics in plaque
erosion specimens. In this study, we investigated the roles of biomechanics and inflammation in
plaque disruption. We hypothesized that solid mechanical stresses and strains in the vessel wall are
associated with inflammatory markers in plaque rupture but not in plaque erosion.
4.2 Methods
4.2.1 Overall Approach
We used a histology-based, lesion-specific computational modeling technique to calculate the dis-
tribution of stresses and strains in the walls of atherosclerotic plaques. We investigated lesions
from four classifications: plaque erosion, plaque rupture, thin-cap fibroatheroma (TCFA, some-
times called “vulnerable” plaques), and thick-cap fibroatheroma (ThCFA, sometimes called “stable”
plaques). We then studied the relationship between solid mechanics and markers of the pathogenesis
of atherosclerosis and inflammation that have been associated with plaque rupture.
4.2.2 Human Tissue Histology
We obtained de-identified human coronary artery specimens from an existing tissue bank of hearts
at CVPath Institute, Inc., obtained as a consultation service for the Maryland Office of the Chief
Medical Examiner. Tissue harvest was described previously [30, 136]. We studied 32 plaque ero-
sion, 14 plaque rupture, 14 TCFA, and 14 ThCFA specimens. Consecutive serial cross-sections
for each subject were stained with Movat’s pentachrome for lesion morphology and immunohisto-
chemically with antibodies for CD68 for macrophages (Dako M0814), Factor VIII for endothelium
(Strategic BioSolutions S40036NDI-D0), MMP1 for this collagenase (Enzo Life Sciences ADI-
905-472), MMP9 for this elastase (Spring Bioscience E3660), a combination of CD31 and CD34
for vasa vasorum (Dako M0823 and Cell Sciences MON1164), smooth muscle actin for smooth
muscle cells (Dako M0851), and TUNEL for apoptosis (Roche 12 156 792 910). Brightfield images
of Movat’s pentachrome and immunohistochemistry were acquired with a 4x objective and automat-
ically stitched together using Microsoft Image Composite Editor (Microsoft Research, Redmond,
WA). Confocal microscopy images of TUNEL staining were obtained with a 20x objective and
automatically stitched together using Leica LAS AF (Leica Microsystems, Buffalo Grove, IL).
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4.2.3 Image Segmentation
Movat’s pentachrome images were automatically segmented to identify the composition and spa-
tial distribution of tissue components using custom Matlab software (Figure 4.1). We used k-
means clustering and Euclidean distance algorithms to identify the presence of fibrous, cellular,
lipid/necrotic core, and calcified tissue based on staining color [124]. An expert observer mod-
ified this segmentation as necessary where, for example, calcium had shattered or necrotic core
had shredded during sectioning. Then, the lumen and periadventitial borders were traced using an
implementation of the Live Wire algorithm [125].
4.2.4 Computational modeling approach
Based on this segmented map of tissue composition, we developed a lesion-specific computer model
of the distribution of stresses in a cross-section of each of the 74 vessels. We used an established fi-
nite element analysis modeling technique implemented in Ansys 14.0 software [56]. We calculated
maps of the relative distribution of Von Mises Stress and Strain in each vessel using this technique.
This technique does not compute the exact magnitude of stress and strain because it does not incor-
porate residual stress. Therefore, to compare values between lesions, we computed the stress and
strain excursion, defined as the percent difference of stress or strain from the lesion’s median value.
4.2.5 Computational Solid Mechanics Assumptions
We used an established 2D, lesion-specific modeling approach to simulate mechanical stresses and
strains within cross-sections of coronary atherosclerotic plaques [56]. Implemented in Ansys 14.0
software (Ansys, Inc., Canonsburg, PA), this model was based on pressure-fixed histology sections
stained with Movat’s pentachrome for morphology and then segmented. Because this tissue is
pressure-fixed, we do not have data on the stress-free conformation of each vessel and therefore
cannot easily compute the residual stress values. Consequently, this model is useful for generating
the relative distribution of stresses but not exact magnitudes.
Linear, elastic, isotropic material properties were used for all tissue components [100]. Al-
though biological tissues are known to be nonlinear, viscoelastic, and anisotropic [12, 101, 102],
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Figure 4.1: Histology segmentation: We segmented histologic cross-sections of human coronary
arteries stained with Movat’s pentachrome (left) in order to determine their composition (right)
on a lesion-specific basis. Based on staining color, we identified whether tissues were fibrous,
cellular, lipid/necrotic core, or calcified. We also traced the lumen and external border using an
implementation of the Live Wire algorithm [125].
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assignment of such material properties to pressure-fixed tissue is mathematically complex and re-
quires a battery of simplifying assumptions. For example, properly applying anisotropic material
properties in a subject-specific model of a complex lesion requires knowledge of fiber directions
that we do not have, and therefore we assume isotropic material properties.
Material properties of vascular tissues can be approximated with a bilinear stress-strain curve,
with a break point between the two realms occurring slightly below our fixation pressure. Below
this threshold, very little stress is generated as the vessel inflates. Therefore, although we are unable
to calculate the stresses in the wall from blood pressures below diastole, we assume these stresses
are relatively low. The relative contribution from stresses above diastolic pressure is much greater
(and is the basis for our model), which is why we can use our technique to determine the relative
distribution of high and low stress and strain but not the exact magnitude.
To model each vessel, we generated a fine-resolution finite element mesh of several hundred
thousand elements between the lumen and periadventital boundary. For each element, we used
a rule-of-mixtures approach [100, 101] to estimate the elastic modulus for that element, based on
our segmented pentachrome image. We then simulated an incremental pressure of +40 mm Hg
(approximately equal to the difference between diastole, the pressure at which the vessel was fixed,
and systole) normal to the lumen. The resulting Von Mises stress and strain distributions for each
vessel were generated, representing the distribution of stresses in the lesion at peak systole.
4.2.6 Computational “pre-inflation” of histology specimens
Some vessels suffered from histology artifacts such as compression along one axis. These artifacts
were apparent because the lumen was not approximately circular, as would be the case in vivo in a
pressurized vessel (Figure 4.2, left). The consequence of this artifact in our mechanical model was
an artificially-high region of both stress and strain at sites of highest deformation (Figure 4.2, mid-
dle). These obscured the physiological stress and strain distribution, and therefore, we “pre-inflated”
each vessel to allow it to distend into a more natural starting conformation. For 10 iterations, we
applied a +40 mm Hg incremental pressure normal to the lumen, computed the new conformation
of the vessel, and then remeshed the vessel to overcome highly-skewed elements. The final iteration
was used for our analysis (Figure 4.2, right) and did not exhibit local stress concentrations at sites
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Figure 4.2: Preinflation technique for mechanical modeling: Many histology specimens suffered
from fixation and embedding artifacts, such as the vessel at left, which is horizontally compressed
relative to its in vivo conformation where the lumen would be mostly circular. Consequently, the
computed stress and strain distributions were skewed in regions of high deformation during compu-
tational analysis (middle). Therefore, we “pre-inflated” vessels by simulating pressure normal to the
lumen, allowing the vessel to deform, and remeshing the vessel for 10 iterations. This extra process-
ing step minimized the effect of tissue artifacts and presented us with more physiologically-relevant
anatomy for our analysis (right).
of histology artifacts. Sensitivity analysis on the number of iterations revealed that after 10 steps,
results were not significantly affected.
4.2.7 Morphology and Composition
We calculated the relative composition of each lesion phenotype from image segmentation results.
We also evaluated several geometric parameters to evaluate whether the shape of lesions differed
by phenotype. We computed plaque burden (percent of area inside internal elastic lamina [IEL]
containing lesion), lesion cross-sectional area (area of tissue inside the IEL), vessel radius (comput-
ing the smallest possible circle to contain each vessel), vessel eccentricity (distance between lumen
centroid and IEL centroid, normalized to vessel radius), and the average thickness of the media
(computing the distance between the inner and outer boundaries of the media, where present) [126].
4.2.8 Mechanics and Tissue Marker Analysis
To evaluate if mechanical stress and strain was associated with positive staining for each of the 7
tissue markers, we registered each stained image against the pentachrome image that was the ba-
sis for mechanical modeling. We traced the lumen in each image and performed rigid registration
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Figure 4.3: Stress and strain excursion association with positive staining: Von Mises stress and
strain excursion were computed for each lesion by breaking down each vessel into a fine-resolution
mesh. After sorting the elements in order of increasing stress (or strain) excursion, we pooled
results into a baseline group (excursion < 0.25) and tertiles or deciles containing an equal number
of elements. Thus, higher-numbered groups (Figures 4.7, 4.8, 4.9, 4.10, 4.14, and 4.15) represent
regions of higher stress or strain excursion. Negative stress excursion represents stress below the
median value, not a negative magnitude of stress or strain.
using cross-correlation of the distance of the lumen border from its centroid to determine the neces-
sary degree of rotation [126, 137]. Regions exhibiting histology artifacts such as folding or ripping
were locally excluded from analysis. Images were thresholded to identify positive staining using
empirically-determined color levels. For each element of the fine-resolution mesh used for compu-
tational mechanics, we determined the stress and strain excursion, and whether there was positive
staining.
To determine if there was an association between stress/strain excursion and each stain, we
pooled results within each of the four lesion phenotypes and sorted them in order of ascending
stress or strain excursion (Figure 4.3). We then divided each phenotype into a baseline group with
excursion < 0.25, and then tertiles and deciles of equal-number elements.
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4.2.9 Total Staining
To evaluate the total expression of each marker per vessel, we thresholded each stained image and
calculated the percent of each vessel with positive staining. Results were tallied for each phenotype.
4.2.10 Endothelial Denudation and Apoptosis
To determine the extent of endothelial apoptosis and denudation, we quantified the amount of pos-
itive staining for Factor VIII and TUNEL within 10 µm of the lumen border. We manually traced
the lumen of each image then dilated the contour using a signed distance function. We tallied the
percent of positive pixels within this region for each phenotype. Sections with significant thrombus
adhered to the wall were excluded because we could not differentiate between positive staining from
endothelium or from thrombus.
4.2.11 Statistical Analysis
To evaluate differences between tertiles and deciles in our mechanics and histology analysis, we
performed a chi-squared analysis to determine if an association existed. If so, we subsequently
performed a two-proportion post hoc test to compare each tertile or decile to its baseline. After
Bonferroni correction for multiple comparisons with α=0.05, any post hoc test with p < 0.0045 was
considered significant.
For total staining, endothelial denudation and apoptosis, and morphology and composition anal-
yses above, statistical differences between phenotypes were assessed with one-way ANOVA fol-
lowed by Tukey’s honestly significant difference post hoc test. After Bonferroni correction for
multiple comparisons with α=0.05, any post hoc test with p < 0.008 was considered significant.
4.3 Results
4.3.1 Mechanics
We successfully segmented 32 eroded plaques, 14 ruptured plaques, 14 TCFA, and 14 ThCFA
plaques (Figure 4.1) and calculated the lesion-specific distribution of Von Mises stress and strain
(Figure 4.4) for each.
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Figure 4.4: Stress and strain modeling: We computed the relative distribution of Von Mises stress
and strain for each lesion. Shown here are stress and strain maps for the two vessels segmented in
Figure 4.1, displayed as excursion (normalized difference from the median).
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4.3.2 Morphology and Composition
There was no difference in the proportion of lesion made of fibrous tissue or lipid/necrotic core
between any of the phenotypes (Figure 4.5). Eroded plaques contained significantly more cellular
tissue than ruptured or TCFA plaques but were not different from ThCFA plaques. Eroded and
ThCFA plaques also had significantly less calcium than ruptured plaques. Eroded plaques had less
calcium than TCFAs (p < 0.05). Eroded plaques had significantly smaller radii than TCFA plaques
(p < 0.008) but were not different from ruptured or ThCFA plaques (Figure 4.6). There was no
difference in plaque burden or eccentricity between lesions, but the cross-sectional area of eroded
plaques was less than ruptured or TCFA plaques (p < 0.05).
4.3.3 Inflammatory Markers
CD68, MMP1, MMP9, and Apoptosis staining varied positively with increasing mechanical strain
excursion for ruptured and TCFA plaques (Figure 4.8, Figure 4.7). No such association was ob-
served for eroded and ThCFA plaques for these same markers. Characteristic associations between
these markers and mechanical stress excursion were not observed (Figure 4.10, Figure 4.9). Without
regard to mechanics, ruptured and TCFA plaques exhibited significantly higher mean staining across
the entire section for MMP9 (Figure 4.11) and apoptosis (p < 0.008) (Figure 4.13) as compared to
eroded and ThCFA plaques.
4.3.4 Media
Smooth muscle actin (SMA) varied positively with increasing mechanical strain excursion for
eroded and ThCFA plaques. It varied negatively for TCFA plaques, and had no dominant asso-
ciation for ruptured plaques. Similarly, the total staining for SMA exhibited the opposite trend than
for inflammatory markers: across the entire vessels, eroded plaques had significantly more smooth
muscle than did ruptured plaques (p ¡ 0.008) (Figure 4.12). Mean thickness of the media was sig-
nificantly higher (p < 0.008) in eroded and ThCFA plaques than ruptured plaques (Figure 4.12).
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Figure 4.5: Relative composition: Based on image segmentation (Figure 4.1), we calculated the
relative composition of lesions for each of the four phenotypes. Plaque erosion specimens were
significantly more cellular and less calcified than ruptured plaques.
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Figure 4.6: Morphological metrics: We calculated vessel radius (by circumscribing a circle around
each vessel, upper left), the plaque burden (the percent of the area inside the IEL containing lesion,
upper right), the eccentricity (distance between lumen centroid and IEL centroid, normalized to
vessel radius, lower left) and area containing tissue inside the IEL (lower right). Differences between
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Figure 4.7: Positive staining and mechanical strain: We examined positive staining for inflamma-
tory markers in images registered against Von Mises strain maps (Figure 4.4). We divided strain
excursion into a baseline group (excursion < 0.25) and tertiles of equal number of elements (see
Figure 4.3) then examined the frequency of positive staining associated with each level of mechan-
ical strain. Inflammatory markers in ruptured plaques and TCFAs varied positively with increasing
strain, whereas eroded plaques and ThCFAs did not vary as dramatically. Thresholding for positive









































































































































Figure 4.8: Positive staining and mechanical strain: We examined positive staining for inflamma-
tory markers in images registered against Von Mises strain maps (Figure 4.4). We divided strain
excursion into a baseline group (excursion < 0.25) and deciles of equal number of elements (see
Figure 4.3) then examined the frequency of positive staining associated with each level of mechan-
ical strain. Inflammatory markers in ruptured plaques and TCFAs varied positively with increasing

















































































































































































































































































































































Figure 4.9: Positive staining and mechanical stress: We examined positive staining for inflamma-
tory markers in images registered against Von Mises stress maps (Figure 4.4). We divided stress
excursion into a baseline group (excursion < 0.25) and tertiles of equal number of elements (see












































































































Figure 4.10: Positive staining and mechanical stress: We examined positive staining for inflam-
matory markers in images registered against Von Mises stress maps (Figure 4.4). We divided stress
excursion into a baseline group (excursion < 0.25) and deciles of equal number of elements (see Fig-
ure 4.3) then examined the frequency of positive staining associated with each level of mechanical
strain.
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Figure 4.11: Eroded and stable plaques have the least total positive staining for inflammatory mark-
ers: Four stains, CD31/CD34 (an endothelial marker for angiogenesis and microvessels, upper left),
CD68 (a macrophage marker, upper right), MMP1 (a collagenase, lower left), and MMP9 (a gelati-
nase, lower right) all exhibit the same relative levels of staining. Ruptured plaques and TCFAs
exhibited the highest levels of positive staining, and eroded plaques and ThCFAs exhibited the low-
est.
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Figure 4.12: Media is lost in ruptured plaques relative to eroded plaques: Immunohistochemistry
for smooth muscle actin (top) revealed that eroded plaques have significantly more smooth muscle




Focusing specifically on the lumenal endothelium, there was no significant difference in endothelial
apoptosis between the four phenotypes of plaques. There were significantly more (p < 0.008) Fac-
tor VIII-positive cells in eroded plaques than in ruptured or TCFA plaques (Figure 4.13). Eroded
plaques were not significantly different from ThCFA plaques. Across the entire vessel, there was no
outstanding association for either of the endothelial markers CD31/CD34 or Factor VIII with either
stress or strain for any of the phenotypes (Figure 4.14, Figure 4.15).
4.4 Discussion
In this study, we demonstrated differences in composition, mechanics, and inflammation between
plaque rupture and plaque erosion, suggesting that considerably different etiologies are at play in
each phenotype. With increasing mechanical strain, there is no corresponding increase in inflam-
mation in plaque erosion, whereas these two properties are closely associated in plaque rupture.
We also noted numerous similar characteristics between plaque rupture and its vulnerable pheno-
type the TCFA, as well as similarities between eroded and stable plaques. Both eroded and ThCFA
phenotypes express relatively higher levels of smooth muscle cells and have thick, intact media,
while the opposite is true for both ruptured plaques and TCFA. These findings are consistent with
present understanding that inflammatory processes are necessary for progression to plaque rupture
and suggest that alternative mechanisms must be considered to understand and prevent plaque ero-
sion. These also suggest that at least a subset of ThCFA plaques may be a “vulnerable” phenotype
for erosion.
The divide in etiologies is most apparent in the relationship between mechanical strain and
inflammatory markers. With increasing strain, CD68, MMP1, MMP9, and apoptosis all increased
in TCFAs and ruptured plaques. In ThCFAs and eroded plaques, however, we observed no such
association between inflammation and strain. Macrophages and MMP1 have been shown previously
to be stress and strain sensitive in atherosclerotic lesions [56]. Therefore, their lack of response in
this subset of lesions, not to mention their lower overall staining in these same lesions, suggests that
plaque erosion is not a consequence of the inflammatory processes leading to plaque rupture.
This difference between plaque rupture and plaque erosion may have significant implications
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Figure 4.13: Apoptosis and Factor VIII for whole vessel and near lumen: Plaque erosion has been
hypothesized to result from endothelial denudation, possibly resulting from apoptosis. When ex-
amining the whole vessel, eroded plaques are significantly less apoptotic then ruptured plaques or
TCFAs and have slightly less Factor VIII. When isolating the endothelium (by examining a region
within 10 µm of the lumen) eroded plaques did not have a significantly greater number of apoptotic















































































































































































































































































Figure 4.14: Positive staining for endothelial markers and mechanical stress and strain: We ex-
amined positive staining for endothelial markers in images registered against Von Mises stress and
strain maps (Figure 4.4). We divided stress excursion into a baseline group (excursion < 0.25)
and tertiles of equal number of elements (see Figure 4.3) then examined the frequency of positive
staining associated with each level of mechanical strain.
for patient care. Whereas plaque rupture is largely an inflammatory disease, plaque erosion appears
to be less so. Anti-inflammatory therapeutic techniques used to treat atherosclerotic plaques may
not be appropriate to prevent plaque erosion.
This is not an idle comment. Two major clinical trials (CIRT and CANTOS) have recently
been launched investigating whether anti-inflammatory strategies will reduce cardiac event rates
[138, 139]. These trials are motivated by prior studies indicating positive associations between C-
reactive protein (CRP) levels and incidence of cardiac events [140–142]. While CRP screening
may identify patients with inflammation at risk of plaque rupture, these trials are not likely to target
patients at risk of plaque erosion. While much is still unknown about the exact mechanism of
erosion, our data suggests that its etiology differs from that of the current prototypical “vulnerable
plaque” and as such may require a different approach for prevention and treatment.
One hypothesis warranting further investigation is the role of endothelial apoptosis and denuda-
tion in erosion. Previous studies have established this as a likely mechanism [37, 135], but the
















































































Figure 4.15: Positive staining for endothelial markers and mechanical stress and strain: We ex-
amined positive staining for endothelial markers in images registered against Von Mises stress and
strain maps (Figure 4.4). We divided stress excursion into a baseline group (excursion < 0.25)
and deciles of equal number of elements (see Figure 4.3) then examined the frequency of positive
staining associated with each level of mechanical strain.
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elusive. We see significantly less apoptosis in plaque erosion than in rupture or TCFAs when con-
sidering the whole vessel, and when focusing specifically on the endothelium we see no significant
difference in apoptosis between any of the lesion phenotypes.
No difference in endothelial apoptosis in erosion specimens could be explained by denudation: if
the endothelium was absent, then the TUNEL stain could not detect endothelial apoptosis. However,
we saw significantly more Factor VIII, a marker of endothelium, in erosion specimens. This may be
biased by our study methodology: we excluded regions where thrombus adhered to the wall because
of the impossibility of distinguishing whether its source was endothelium or thrombus [143]. But,
regions where thrombus has adhered to the wall are precisely the sites where denudation is expected.
Despite this limitation, these findings are perplexing. If denudation occurs because of a “sick”,
apoptotic endothelium, we would still expect more apoptosis and much less Factor VIII near the
lumen in erosion. If widespread apoptosis leading to denudation is not the explanation, further
refinement of this etiological hypothesis is warranted.
Another noteworthy difference between eroded and ruptured plaques is the proliferation of
smooth muscle cells and the media. We observed that the media was significantly thicker in erosions
and ThCFAs than in ruptures. Loss of media in advanced atherosclerotic plaques is an established
phenomenon [10,27], but does not seem to be at play in either eroded or ThCFA plaque phenotypes.
Smooth muscle cells are essential for pathological intimal thickening to occur [17, 39] and so their
loss in vulnerable and ruptured plaques likely sets up a different biomechanical environment than
in erosive-phenotype plaques. This may also have fluid dynamics consequences, as the degree of
stenosis may modulate shear stress magnitudes.
We did not observe as strong a relationship between stress and expression of inflammatory
markers as we did with strain. Although high magnitudes of stress are necessary for tissue fissur-
ing to occur, cells do not directly sense stress. Instead, they sense strain, which is deformation
of the tissues. As the vessel wall distends under pulsatile blood pressure, cells deform and, via
mechanotransduction such as cytoskeletal interaction with membrane-bound proteins or deforma-
tion of surface receptors, modulate biological processes. Therefore, that inflammatory processes are
more strongly associated with strain is not unexpected. However, it is interesting to note that eroded
and ThCFA plaques, which were more cellular and therefore should experience greater magnitudes
87
of strain for given pressures, did not demonstrate an association between strain and inflammation.
Ruptured and TCFA plaques, which were less cellular and more calcified and should be stiffer,
showed a much stronger association between strain and inflammation.
Our histology-based mechanical modeling and data analysis techniques are based on the meth-
ods of Hallow et al. [56]. Whereas we compared plaque rupture, erosion, TCFA, and ThCFA,
Hallow et al. compared plaques at four stages of progression based upon the AHA classification
system (see section 1.3.1) without respect to endpoints or vulnerability. Our plaques were clas-
sified based upon the scheme of Virmani et al. [15] (see section 1.3.2), which stratifies plaques
based upon different criteria. The lesions in our study could have been classified as intermediate,
advanced, or mature in the prior study’s classification system. Therefore, although we both inves-
tigated the assocation between macrophages and MMP1 with stress and strain, we cannot directly
compare any groups of plaques between the two studies. In the study of Hallow et al., the associ-
ation between MMP1 and macrophages with stress and strain varied considerably among the four
stages of lesion progression, and thus we are not surprised to see that our results do not match, given
the non-overlapping classification schemes.
An established family of characteristics of plaque rupture is composition and morphology of
lesions [15, 22, 23, 111]. Factors like the size and shape of necrotic core and fibrous cap thickness
affect the distribution of mechanical stresses, which leads to plaque vulnerability and potentially
then rupture. In the present study, plaque burden and eccentricity, as well as proportion of fibrous
and lipid/necrotic tissue, were not different. Radius, lesion area, and percent cellularity and cal-
cification were different between erosion and rupture or TCFA, but other than calcification, which
may play a role in lesion stability [109, 144], these are not established characteristics of plaque
vulnerability. That the morphology and composition were not, on the whole, different between
plaque phenotypes strengthens our conclusion that inflammatory response to biomechanics is a key
differentiator between plaques that rupture and plaques that erode.
Because we used pressure-fixed tissue as the basis for our mechanical modeling, we were only
able to compute the relative distribution of stress and strain, not the absolute magnitude of either
value [57]. Other studies modeling plaque rupture have attempted to discern a threshold for which
a fibrous cap breaks [85, 105, 114]; no similar analysis is possible with our technique. For plaque
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erosion, no gross tissue damage is expected. Unfortunately, because we do not have the ability to
calculate absolute magnitudes, we cannot evaluate how the level of stress directly compares between
rupture and erosion.
Additionally, erosion is not thought to be an acute event [33]. In many cases, a mural thrombus
accumulates over a period of approximately a week [33], in contrast to rupture, where thrombosis
is typically much more acute. As this thrombus organizes and heals in subjects with erosion, the
vessel remodels and the lumen reshapes. Consequently, a histological cross-section of a vessel at
the onset of plaque erosion may reveal different information than a cross-section from the time of
death. With no present way to detect the initiation of plaque erosion in humans, we are limited to
studying autopsy specimens until our understanding of the phenomenon improves.
There is great need for means to detect and treat plaque erosion. In this study, we have shown
that the inflammatory response to the mechanical environment in atherosclerotic plaques is charac-
teristically different between plaque rupture and plaque erosion. Ruptured plaques have a similar
inflammatory response to mechanics as TCFAs, and eroded plaques respond similarly to ThCFAs.
It is likely that management and treatment for patients experiencing plaque erosion will require an
entirely different approach than current protocols used for those with plaque rupture.
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CHAPTER V
COMPUTATIONAL FLUID DYNAMICS SIMULATIONS OF FLOW IN PLAQUE
EROSION
5.1 Introduction
The role of biomechanics in plaque disruption is widely studied: solid mechanics helps explain how
a pressurized vessel wall experiencing a local maximum of stress can fissure and lead to plaque
rupture. Pressurized blood isn’t static, however, and fluid flow may play a role in plaque disruption
as well. Although a direct link between rupture and flow mechanics like wall shear stress has not
been clearly demonstrated, the role of shear stress in atherogenesis is well established [9, 81] and
plaque rupture is known to occur preferentially downstream of bifurcations [145]. Low magnitude
and oscillatory wall shear stress patterns tend to dominate in regions where plaques form, whereas
higher magnitudes of wall shear stress are typically atheroprotective. Very high magnitudes of wall
shear stress have been reported to cause endothelial damage (typically > 70 dynes/cm2) or acute
denudation (around 400 dynes/cm2) [41, 55, 146].
In addition to modulating the progression of atherosclerosis, flow also affects thrombosis: high
shear activates von Willebrand factor and results in platelet adhesion [47]. Given these relation-
ships and the fact that solid mechanics alone has not yet explained why certain vulnerable plaques
suddenly rupture, a role for fluid mechanics in both plaque rupture and plaque erosion deserves
consideration. Initial case reports have shown a correlation between shear and site of plaque rup-
ture [98, 99], but to date no study has considered the role of shear in localization of plaque erosion.
A leading hypothesis regarding the mechanism of plaque erosion is the loss of endothelial cells:
a thrombogenic surface is presented to the blood pool when endothelium is denuded. This desqua-
mation has been replicated in animal models by inducing apoptosis [37, 135], and both apoptosis
and endothelial dysfunction may be induced by flow patterns [28]. Disturbed flow patterns have
been shown to induce an erosion-like phenotype of apoptotic and detached endothelial cells in rab-
bits [135], although no animal model of spontaneous erosion exists.
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Another possible mechanism by which flow might result in erosion is through extremely high
magnitudes of shearing flow. This could forcefully detach endothelium, especially if it’s already
apoptotic. Mural thrombus formation would also be aided in this high-shear environment. Given
that plaque erosion frequently occurs in women [17] and that women, on average, have narrower
coronary arteries than men [147, 148], elevation of shear stress in patients with plaque erosion is
possible. In this study, we used patient-specific computational fluid dynamics modeling to simulate
blood flow through coronary arteries in patients with plaque erosion. We hypothesized that patients
with plaque erosion will experience locally elevated WSS magnitude in regions where erosion has
occurred. We also examined the local curvature and branching of human coronary arteries with
eroded plaques in hearts obtained at autopsy. We hypothesized that curvature and branching would
be associated with erosion location.
5.2 Methods
We obtained coronary biplane angiograms from three patients who presented to the Emory Uni-
versity catheterization lab (Figure 5.1) and received a diagnosis of plaque erosion using optical
coherence tomography (OCT, Figure 5.2). All patient research was performed under the approval
of the Emory University Institutional Review Board.
5.2.1 3D Vessel Reconstruction
We reconstructed the anatomy of culprit arteries using Paieon CardioOp-B software (Paieon, Inc.,
New York City, sold as CV-3D by Toshiba Medical Systems, Inc., Tustin, CA). This commercial
software allowed us to segment the borders of angiograms at diastole. We selected angiograms
performed immediately after thrombectomy for two patients and at 12-day follow up catheteriza-
tion after thrombectomy for the other patient in order to reconstruct anatomy without influence of
the erosion’s thrombus (Figure 5.3). Paieon produced coordinates of centerlines and correspond-
ing radii for the culprit vessel and any nearby branches. Centerlines and radii were imported into
custom Matlab software (R2011b, Natick, MA) to generate a 3D point cloud representing vessel
borders, which was then imported into Geomagic Studio 2012 (Morrisville, NC) in order to gener-
ate a smooth 3D surface.
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Figure 5.1: Plaque erosion in right coronary artery: This patient presented to Emory University Hos-
pital and underwent cardiac catheterization. A large thrombus was identified in the right coronary
artery, circled above in red. OCT identified the source of the thrombus as an eroded plaque.
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Figure 5.2: Optical coherence tomography identification of plaque erosion: Intravascular OCT re-
veals cross-sectional anatomy of a coronary artery. Thrombus appears at the bottom of the image as
positive signal with jagged edges. We approximated the vessel boundary (red line) although behind
thrombus, exact segmentation is impossible.
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Figure 5.3: Segmentation of culprit vessels in Paieon software: We semi-automatically identified
the silhouette of vessels in biplane angiograms for each of three patients using Paieon software.
5.2.2 Meshing and Flow Extensions
We then imported geometry into Ansys ICEM meshing software (Canonsburg, PA) to generate a
3D finite element mesh for computational fluid dynamics. Models were generated with between 1.2
and 1.9 million tetrahedral elements), as well as a prism boundary layer (8 layers deep, with a linear
element size growth factor of 1.1 sized such that the innermost element was the same volume as the
adjacent tetrahedral element). We added flow extensions to all inlets and outlets by projecting the
contour of the inlet or outlet straight outward. Inlet flow extensions were one diameter long, and
outlet flow extensions were 7 diameters long.
5.2.3 Computational Fluid Dynamics
Patient-specific computational fluid dynamics simulations were performed using Fluent 14.0 soft-
ware (Ansys, Inc., Canonsburg, PA). We simulated pulsatile blood flow through rigid walls by pre-
scribing a generic coronary flow waveform (Figure 5.4) as a blunt velocity inlet into our flow exten-
sion. This yielded a plug-shaped velocity distribution entering our model geometry. We simulated
three continuous cardiac cycles and discarded the first two in order to remove transient artifacts from
our model. We simulated 300 timesteps per cardiac cycle (for a total of 900 timesteps) for a heart
rate of 75 beats per minute (0.0026667 seconds per timestep). Outlets were traction-free pressure
outlets. Blood was modeled as a Newtonian fluid with density 1060 kg/m3 [35] and dynamic viscos-


















Coronary Velocity Waveform, One 
Cardiac Cycle 
Figure 5.4: Coronary velocity waveform: We prescribed a blunt velocity profile through an inlet
flow extension into each CFD model. This waveform was derived from a typical patient, as patient-
specific velocity data were not available. (Waveform courtesy of Drs. Luke Timmins and Habib
Samady).
Green-Gauss node based spatial discretization of pressure, momentum, and time. Convergence was
prescribed as velocity and continuity residual < 10−6.
5.2.4 Rendering and Postprocessing
Results were exported from Fluent in Ensight Gold format. Using custom Matlab code, we calcu-
lated temporal mean WSS and oscillatory shear index (using the algorithm of Moore et al. and a
threshold of π6 ). All data were rendered in Paraview (Kitware, Inc., Clifton Park, NY). We gener-
ated images of WSS and OSI, as well as animations of instantaneous WSS, streamlines, and particle
paths. To assess that we had achieved mesh convergence, we re-meshed the same geometries at half
resolution and confirmed that neither mean WSS nor OSI changed in distribution.
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Figure 5.5: Identification of local curvature: For each lesion identified in x-ray angiograms, we
tallied whether the local region was serpentine (left), gradually curving (middle), or locally straight
(right).
5.2.5 Anatomical Location of Plaque Erosion and Rupture
We identified the site of plaque erosion and rupture in paired single-plane x-ray angiograms from
explanted autopsy hearts [30]. These were a different set of individuals than those used for CFD.
Hearts from the Maryland Medical Examiner’s Office were perfused with barium gelatin and then
x-rayed onto film, which was subsequently digitized with a flatbed scanner. Histological analysis of
the hearts resulted in identification of plaque erosion in 13 hearts and plaque rupture in 6. Based on
the site of greatest stenosis and histological description of the site of thrombosis, we identified geo-
metric features of the coronary anatomy for each patient. We tallied whether each was in a section of
vessel that was nearly straight, gradually curved, or highly serpentine (Figure 5.5). We also tallied
whether bifurcations or trifurcations existed within 2.5 diameters length upstream, downstream, or
immediately across from the site of thrombosis.
5.3 Results
5.3.1 Computational Fluid Dynamics
We simulated blood flow in all culprit vessels, one each of the left anterior descending (LAD), left
circumflex (LCx), and right coronary artery (RCA). In all three, thrombus location coincided with
relatively low magnitudes (< 2 Pa) of mean WSS, but these regions were neither the lowest WSS
in the vessel nor the only region with mean WSS < 2 Pa (Figure 5.6). The spatial distribution of
peak WSS was nearly identical to that for mean WSS. Again, maximum WSS magnitude at sites of
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Table 5.1: Tallies of local curvature at sites of plaque erosion and plaque rupture
Lesion Type Serpentine Gradually Curving Straight Total
Erosion (autopsy heart) 4 (30.8%) 4 (30.8%) 5 (38.4%) 13
Erosion (cath lab) 1 (33.3%) 1 (33.3%) 1 (33.3%) 3
Rupture (autopsy heart) 1 (16.7%) 4 (66.7%) 1 (16.7%) 6
Table 5.2: Tallies of nearby branching (within 2.5 diameters) at sites of plaque erosion and plaque
rupture
Upstream Branch Downstream
Lesion Type Branch at Site Branch Total
Erosion (autopsy heart) 8 (61.5%) 0 (0%) 3 (23.1%) 13
Erosion (cath lab) 0 (0%) 0 (0%) 1 (33.3%) 3
Rupture (autopsy heart) 1 (16.7%) 2 (33.3%) 1 (33.3%) 6
erosion was neither the highest for the vessel nor was it unique. Maximum WSS magnitudes at sites
of erosion was < 12 Pa.
We found no association between thrombus location and OSI (Figure 5.7). Streamline analysis
revealed some helical flow patterns within the region for part of the cardiac cycle, but this too was
not unique to the region of thrombus formation (Figure 5.8). We visually observed essentially no
reversal of flow in the region of the thrombus, although one lesion (LCx) was distal to a bifurcation
and some reversal was observed upstream at the site of bifurcation.
5.3.2 Anatomical Location of Thrombi
Local curvature and downstream bifurcation were not associated with site of plaque erosion in ex-
planted hearts, but an upstream bifurcation or trifurcation existed in 8/13 erosions. Among biplane
angiograms from living patients (n=3), sites of erosion were again split evenly among local curva-
ture. One patient had nearby upstream bifurcation, and one had adjacent downstream bifurcation.
Of rupture specimens, two-thirds were in gradually curving regions, one-third had a bifurcation at
the site of rupture, and one specimen had a nearby downstream trifurcation. Data are tallied in
Tables 5.1 and 5.2.
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(a) Patient 1 (b) Patient 2
(c) Patient 3
Figure 5.6: Mean Wall Shear Stress: We computed the temporal mean WSS for all three patients.
All patients’ erosions were at sites containing low magnitudes of WSS, but these this is not a unique
feature to the erosion sites.
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(a) Patient 1 (b) Patient 2
(c) Patient 3
Figure 5.7: Oscillatory shear index: We calculated oscillatory shear index, a measure of the dura-
tion of the cardiac cycle when flow deviates from its mean direction by more than π6 radians. No
remarkable patterns in OSI related to plaque erosion location were identified.
99
Figure 5.8: Transient helical flow structures: Occasional helical flow structures would appear at the
site of plaque erosion when visualized by streamline analysis.
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5.4 Discussion
This initial modeling study suggests that flow does not seem to be a major factor in the localization
of plaque erosion. In all three cases, neither the local flow environment nor the surround geometry
were particularly remarkable. High wall shear stress, which we hypothesized would induce plaque
erosion by damaging endothelium via shear, is not present in any of these patients at the site of
thrombus formation. If anything, WSS tended to be low at these sites. Although we cannot rule out
that very high WSS is sufficient to induce plaque erosion, we can conclude that it is not necessary.
Low WSS is known to be associated with increased apoptosis. However, this relationship is
complex [86,149,150]. There were numerous other sites in each culprit vessel that also experienced
low mean WSS, and yet no erosion occurred at those sites. Helical flow patterns were also present in
the eroded regions during part of the cardiac cycle, but these too were present in segments without
erosion. Thus, the relationship between plaque erosion and fluid mechanics is complex and possibly
multifactorial, if one exists at all.
A major obstacle in most clinical plaque disruption research is the lack of data from before
induction of thrombosis. In plaque erosion, a mural thrombus accumulates over a period of weeks
[33], and during this time vascular remodeling may occur. If vasospasm induces plaque erosion, as
has been hypothesized [34,41], the fluid environment could well play a role, as it would lead to very
high magnitudes of WSS resulting in denudation. However, vasospasm is a transient phenomenon
[10]. No evidence of stenosis from such an event (or from vascular remodeling) was observed in
our angiograms, but patients undergoing cardiac catheterization are given vasodilating drugs, so no
evidence is expected. Ideal computation fluid dynamics modeling would simulate coronary flow
based upon anatomies approximately two weeks before diagnosis of erosion, but such a dataset will
continue to be nonexistent without prospective diagnostic criteria for erosion.
Other challenges when generating relevant vascular geometry include the possibility of throm-
bus in the angiogram. We used angiograms from the end of the procedure (or in one patient’s case, a
follow-up angiogram from several days later) when the thrombus had resolved. Because angiograms
only resolve the lumen of vessels where flow is occurring, any residual mural thrombus would cre-
ate a geometric artifact, artificially narrowing the lumen. We saw no such evidence of stenosis in
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any of the images after thrombectomy, and if it would have occurred, our estimates of WSS should
overestimate the true magnitude. Given that we computed relatively low WSS in regions of erosion,
this possibility seems unlikely.
Geometric modeling assumptions could have affected our results as well. We simulated coro-
nary vessels as rigid structures. In reality, arteries can both distend under pulsatile pressure as well
as bend as the myocardium contracts and expands. This bending has been hypothesized as direct
cause of plaque rupture [110, 151], and although moving walls like alters flow patterns, solid me-
chanical stresses from repeated bending do not appear to be a critical factor in plaque erosion (see
Chapter 4). Still, future modeling using fluid-structure interaction (FSI) would alleviate some of
these artifacts. Adding in patient-specific blood viscosity and using higher-order rheological mod-
els than a Newtonian fluid would further remove modeling assumptions.
Additionally, the software we used to generate 3D geometries from angiograms yields circular
cross-sections for all vessels. In reality, vessel cross-sections are not perfectly symmetric and some-
times are rather elliptical, especially in the presence of atherosclerosis. Although more accurate
geometry could be produced by considering vessel diameter in both views of biplane angiograms,
previous research has shown that patterns of WSS are not significantly altered by assuming a circular
cross section [152].
The opportunity to acquire both pre- and post-procedure biplane angiograms in conjunction
with OCT in a case of plaque erosion is indeed very rare. Although our sample size of three patients
is small, these are very unique data. This study is exploratory in nature but does rule out a very
obvious flow-related etiology as being necessary for plaque erosion.
Our tallies indicate that anatomic features related to flow patterns do not appear associated
with plaque erosion or rupture, although this initial work involves a small sample size and has not
been evaluated statistically. We see the same trends in plaque erosion in both patient and autopsy
angiograms: local curvature of the vessel segment is not associated with erosion, although this
could alter flow patterns. The relationship between WSS and atherogenesis is especially apparent
on the inner edge of curvatures and bifurcations, where low and oscillatory WSS occurs [78]. We
do observe that many plaque erosions happen shortly downstream of vessel branching, but just the
same, many erosions occur in regions without unusual geometry. For this reason, we suggest that
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flow is not a direct modulator of plaque erosion and that biological or solid mechanical explanations
may offer more promise for elucidating the exact mechanism of plaque erosion.
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CHAPTER VI
CONCLUSIONS AND FUTURE DIRECTIONS
6.1 Summary
In this dissertation, we aimed to investigate the role of biomechanics in endpoints of atherosclerosis,
namely (putative) plaque rupture in mice and plaque erosion in humans. We used lesion-specific
biomechanical modeling techniques to simulate solid and fluid stresses at sites of atherosclerosis,
and we investigated how morphology and composition affect the likelihood of plaque rupture or
erosion. These studies revealed how plaques in mice and plaques that have eroded experience
unique distributions of stresses compared to plaque rupture. As such, neither of these situations is
mechanically likely to rupture and should therefore be regarded as distinct phenotypes to which the
standard risk factors for plaque rupture most likely do not apply.
The mouse model of atherosclerosis is a leading tool for studying the progression of atheroscle-
rosis, but rupture in mice is elusive, if not entirely absent. In studies of murine plaques, researchers
often describe plaques as “vulnerable” or “unstable” despite minimal evidence that mouse plaques
rupture in the same way as in humans. Our biomechanical modeling has revealed that the distribu-
tion of solid mechanical stresses is completely different in mice than in humans. Whereas human
“vulnerable” plaques experience local maxima of stress on the thin fibrous cap over a necrotic core,
or on the shoulders of the plaque, murine plaques have the local maxima primarily on the media and
adventitia where no plaque is available to rupture. Thus, descriptions of “vulnerable” plaques in
mice are likely misnomers. If plaques can rupture in mice, they do not appear to do it at the stages
of atherogenesis we studied, which we deliberately selected to represent a cross-section of available
models in terms of time and severity.
The mechanics differ between mice in men at least in part due to differences in morphology and
composition between the species. Plaques in mice are significantly more cellular and less fibrous
than human thin-cap fibroatheromas. Acute models of plaque formation in mice do not form calci-
fications, either micro-scale or macro-scale, distal to the aortic leaflets within the timescale of these
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models. Chronic models do form macrocalcifications and thus appear to be slightly more similar to
human lesions, which form over a period of decades. However, the shape of atherosclerotic plaques
is entirely different in mice than in humans, regardless of timescale. Murine plaques rarely cover the
entire circumference of the vessel, whereas in humans some neointimal hyperplasia is nearly always
observed on the full wall (with the consequence of redistributing mechanical stresses). The overall
plaque burden is significantly lower in mice, and the complexity of lesions, with buried fibrous caps
and multiple lipid pools, is often high in this species.
Mechanics, morphology, and composition differ within human lesions when comparing rup-
tured with eroded plaques, as well as with undisrupted plaques like thin-cap fibroatheromas and
thick-cap fibroatheromas. However, the role of mechanics in differentiating human plaque pheno-
types is more complex than simple distribution of stresses and strains. Using immunohistochemical
detection of inflammatory markers within the lesions in tandem with solid mechanical modeling, we
demonstrated that inflammation is positively associated with strain in ruptured and TCFA plaques,
but not in eroded or ThCFA plaques. This suggests that inflammation is not the driving force in the
progression of plaques to erosion, as well as suggests a novel pairing of varieties of atherothrombo-
sis with “vulnerable” phenotypes for each. Whereas the link between plaque rupture and TCFAs is
well-established, little is known about how plaques progress to erosion.
Although certainly not all ThCFA plaques will erode, so too is the fact that not all TCFAs
will rupture. Thus, further research is necessary to understand the mechanism that initiates plaque
erosion. Because inflammation is lower in eroded plaques than in ruptured and because it does
not appear to be modulated by stress or strain like in ruptured plaques, it does not seem likely
that inflammation is a primary modulator of this process. Therefore, clinical practice may need to
be altered to treat these patients, as anti-inflammatory approaches to lesion management may not
successfully mediate plaque erosion. Differences in media thickness and in the proportional com-
position of smooth muscle cells suggest that a different type of cell proliferation than inflammatory
cells may be a possible target to manage these patients.
Initial modeling provided another biomechanical difference between plaque rupture and plaque
erosion: flow. In plaque rupture, some studies suggest that patterns of shear stress on the endothe-
lium could play a role in modulating the location of plaque rupture. Although our patient sample
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size was small, our modeling did not reveal any obvious connection between flow patterns and
plaque erosion. Erosion tended to happen in regions of low magnitude WSS without much oscil-
lation, but these regions were not unique to the vessel and would not help identify plaque erosion
location without additional factors. Geometric predictors like local curvature and vessel branching
also did not help predict plaque erosion, which is noteworthy because rupture often occurs in regions
of disturbed flow, particularly near branches. That flow does not seem to be associated with sites of
plaque erosion further suggests that the processes resulting in plaque erosion are quite unique from
those leading to plaque rupture.
6.2 Refinement of Research Methods
Our mechanical modeling is based on a powerful, established technique to compute the distribution
of solid mechanical stresses and strains from fixed histology specimens. However, several additions
to this technique could minimize the effects of some of our assumptions. Here, we assume the
magnitude of residual stresses is small relative to the incremental stresses in the wall from the pulse
pressure. Although these magnitudes are likely small, their absence prevents us from estimating the
magnitudes of stress and strain.
Several “inverse method” techniques have been developed that may be able to calculate residual
stresses, given the geometry of fixed tissue [153–155]. These techniques are not currently part of
the finite element software we use, and thus would require advanced computational approaches
to incorporate them into our existing methodology. Such a process would be decidedly nontrivial
to implement, and it would likely fail when used on specimens with histology artifacts. It would
probably be best implemented on our mouse tissues perfused with vascular casting compound, as
they contain the fewest artifacts.
Using an inverse method to calculate stresses would enable estimation of magnitude of stress
and strain, a common concern we heard from reviewers and colleagues at conferences. Although
none of the conclusions in the studies in this dissertation were affected by this detail, another benefit
of being able to calculate the zero-stress conformation of tissues is that we could then apply non-
linear material properties in our model. It has been shown that the tissue components in coronary
atherosclerosis can be closely approximated by bilinear material properties, which we implemented
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in these studies [100]. However, prescribing nonlinear material properties would allow us to use
material models described by other groups, including mouse-specific material properties. Again,
implementing such methods come at the cost of great complexity (and their own set of assump-
tions) but are nonetheless an avenue worth future consideration.
Another material property factor not implemented in the current study is anisotropy of materi-
als. Our reason for omitting this is straightforward: atherosclerotic lesions are far too complex to
implement such details without knowledge of fiber directions. Anisotropic material properties are
routinely described in vascular biomechanical literature where a blood vessel is approximated as a
cylinder, but such a description fails to approximate patient-specific atherosclerotic lesions. Using
registered high-resolution microscopy images of picrosirius red staining under polarized light, one
may be able to derive primary fiber directions on a patient-specific basis. Such an approach would
require advanced image-processing techniques to derive local fiber direction then apply it to the
finite-element model.
Material property assumptions could be further refined by incorporating even more tissue types
into our segmentation. Currently, we identify all tissue as being fibrous, cellular, lipid, or calcium.
Although these describe all major components of lesions, some could be subdivided further to yield
even more specific material properties. For example, Movat’s pentachrome staining differentiates
between collagen and proteoglycans, but we lump both tissue types together as “fibrous”. With
registered picrosirius red staining, we could even differentiate between Type I and Type IV collagen,
which likely have different material properties as well. Taking these and other tissue types into
account would improve accuracy of computational solid mechanics modeling.
Two major limitations to our histological techniques stand out that could be refined upon further
analysis. First, our staining for apoptosis using the TUNEL assay does not conclusively identify
apoptosis in all circumstances: regions of false positives are possible and could be confirmed using
a second apoptosis assay such as staining for caspases or phosphotidylserine. The other histology
limitation in this dissertation was our inability to use Movat’s pentachrome stain in murine tissues.
By identifying a different vascular casting compound that doesn’t absorb the black stain in pen-
tachrome, it’s possible that we could have directly compared human to mouse tissue using the same
stain. Sensitivity analysis showed that using this different stain did not affect our results, but a direct
107
comparison would nonetheless be more ideal. Unfortunately, even if a different vascular casting
compound was identified, the entire study would need to be repeated in its entirety.
In our computational fluid dynamics models, the most physiologically relevant refinement we
could make to our methods would be to include fluid-structure interaction (FSI) and eliminate our
assumption of rigid walls. Such a task would add considerable complexity to our model: we would
need to track the boundary of the coronary arteries across the entire cardiac cycle and, if we wanted
to run full two-way FSI, apply material properties to the wall, even though we have neither thickness
nor composition data for the arteries from our biplane angiograms. This task would be prohibitively
difficult, which it why it was not included in this study. However, the fact remains that arteries move
over the cardiac cycle, and future studies into coronary flow should take this motion into account.
Other simplifying assumptions such as modeling blood as a Newtonian fluid could be removed by
utilizing more complex rheological models.
6.3 Additional Experiments
Additional endpoints could be considered to more thoroughly evaluate our conclusion that plaque
rupture is mechanically unlikely in mice. We considered a range of mouse models encompass-
ing some of the most severe models available, with the thinking that if rupture is unlikely in these
models, it should be even less likely in more moderate models. However, we cannot rule out the pos-
sibility that other models may be strong candidates for rupture without performing similar analysis.
Gender and age are two factors known to modulate the severity of atherosclerosis in mice that were
not thoroughly investigated in our studies. We recommend incorporating female mice into future
studies, as well as adding additional harvest time points in the chronic model of lesion formation,
both shorter and longer than the 1 year time span we considered. Additionally, other mouse models
such as ApoE-/- mice fed different formulations of diet, the ApoE*Leiden mouse, or hypertensive
mice fed DOCA salt might be considered to include a wider cross-section of mouse models.
One might improve our solid mechanical modeling of plaque erosion study in a similar manner
by considering additional histological markers to differentiate between plaque erosion and plaque
rupture. We investigated MMP1 and MMP9 because they are well-established MMPs associated
with plaque progression. However, there are dozens of additional MMPs and four families of tissue
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inhibitors of metalloproteinases (TIMPs) that could be considered as well. Other inflammatory
cell types such as leukocytes could additionally be stained for to derive an even more thorough
understanding of the differences between plaque rupture and plaque erosion. A major limitation to
wanton staining (besides the high cost of antibodies) is that our mechanical modeling is based on
a single histological section, and each additional stain adds 500 microns to the distance from our
Movat’s pentachrome slide. Although morphological differences are small from slide to slide, this
differences compound the farther one travels from the original slide. Thus, although staining for
additional markers may be prudent to help elucidate the mechanism of plaque erosion, judicious
selection of stains is necessary.
Another possibility for a future study would be a full 3D reconstruction of lesions from histol-
ogy. By sectioning an entire lesion and digitally stacking the slides, one might recreate the entire
lesion to provide additional mechanical insight beyond that of a single plane [156]. Such a task
would be technically challenging and time-intensive to implement, but if carefully planned, it may
yield important insights into lesion mechanics. With a full 3D model, one could not only simu-
late the solid mechanical stresses in the wall but also fluid mechanics as well by adding in FSI.
This feature would significantly increase the comprehensiveness of the lesion-specific mechanical
analysis.
Analysis of the role of flow in plaque erosion would be greatly strengthened with a larger patient
sample. Unfortunately, such patients are not frequently identified in the cardiac catheterization
laboratory, and thus the sample size for our present study was quite small. Of those that did arrive,
not all had biplane angiograms acquired, a necessity for 3D reconstruction of vessels. By searching
a longer time frame or by including additional institutions, one might improve the sample size of this
study such that statistical differences between plaque erosion and plaque rupture might be identified.
One aspect not included in our study that should be considered in future CFD analysis of plaque
erosion is comparison to patients with plaque rupture. Although such patients are common and
datasets abound, careful consideration is necessary to design an appropriate study. The degree of
stenosis from a lesion could be the single most important factor modulating the magnitude of wall
shear stress, so careful matching of lesion stenosis is essential to the design of a good study. If
wall shear stress is not a factor in plaque erosion, such consideration might be less critical, and an
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expanded evaluation of the sites of rupture and erosion should be conducted.
Another factor that should be studied further is the pattern of blood swirling around the sites of
lesions. We observed some helical flow structures at the sites of plaque erosion (as well as at sites
away from plaque erosion) that could be further evaluated mathematically by computing the overall
helicity. One factor that would improve the patient-specific accuracy of such analysis, besides FSI,
would be application of patient-specific velocity profiles. Because all of the subjects in our study
arrived in the cardiac catheterization laboratory in an emergency situation, no patient-specific flow
waveform was acquired, as it was not clinically necessary. Future studies could perhaps follow up
with such patients after they leave the cardiac catheterization laboratory to acquire a patient-specific
waveform noninvasively, perhaps with techniques such as Doppler ultrasound.
6.4 Future Research Directions
The long-term clinical goal of the research in this dissertation is to improve patient treatment by
better understanding the mechanisms of plaque erosion and plaque rupture. The big picture right
now is answering the question: why do some plaques progress to form a thrombus? The TCFA
has been identified as the “vulnerable” phenotype for plaque rupture, but not all TCFAs progress to
rupture. Similarly, this research suggests that ThCFAs are a family of plaques in which at least a
subset are likely vulnerable to erosion. Not all ThCFAs progress to erosion either, so it is critical that
future cardiovascular researchers better understand the mechanism that induces plaques to rupture
or erode.
One key possibility for both types of plaques that was not included in this research is vasore-
activity, such as spasm. When this occurs, the mechanics of the media and intima change as the
vessel contracts. So too does the pattern of WSS across the region change as a stenosis is induced.
This shear force could have major consequences for the endothelium and might help explain plaque
erosion. Contraction of the media will result in increased stress throughout a lesion, which could
have great consequences for rupture. FSI modeling of vessels under vasospasm may yield important
insights.
Given that our research has shown that inflammation is not likely the target for plaque erosion,
the role of smooth muscle cells in the progression of ThCFAs into erosions seems another good
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starting point for future studies. How do these cells leave the media, and what induces them to tran-
sition from a contractile to a synthetic phenotype? Do they play a role in signaling for endothelial
apoptosis? If not smooth muscle cells, what causes this apoptosis? And, if apoptosis cannot explain
denudation, what is the actual cause? An animal model of spontaneous plaque erosion would be a
critical tool for studying means to identify and treat patients with erosion, but first these questions
must be answered such that a physiologically-relevant model of erosion can be developed.
Our results indicate that current popular mouse models are not likely relevant for studying
plaque rupture. The distribution of stresses is not on the lesion at all, and instead focuses pri-
marily on the plaque-free media and adventitia. Although this finding may be disappointing for
researchers seeking a mouse model of plaque rupture, this could indicate a new research direction
for those studying aortic aneurysm formation. A number of approaches for inducing abdominal aor-
tic aneurysms in mice exist, and each has benefits and weaknesses. Future research might take into
account the distribution of stresses into the weak portion of the wall when developing new mouse
models or studying existing ones and trying to reconcile how aneurysms in mice apply to those in
humans.
Another finding in our studies of mice was the occurrence of micro-scale calcifications in lesions
on the aortic leaflets. Even young mice under pro-atherogeneic conditions for 8 weeks formed these
calcifications. Given recent studies suggesting a role for microcalcifications in rupture of the fibrous
caps of human plaques as well as other studies suggesting a stabilizing role for macrocalcifications,
the existence of these calcifications should be studied further. Why are they forming in lesions
on the leaflets? Will they result in rupture? Will they stabilize the lesion? Will they progress to
macrocalcifications or remain small? Are they even relevant to human microcalcifications? Are
they relevant to studies of valvular heart disease? These are all questions that should be addressed
through the intersection of computational solid mechanics and biological techniques.
Other phenotypes of plaque disruption should be studied biomechanically as well. Calcified
nodules, although relatively rare, do exist and can result in fatal thrombus. Mechanical modeling
could help identify plaques likely to progress to this stage and understand the function of calcifi-
cation. Similarly, intraplaque hemorrhage is a phenomenon not well understood. Mechanics could
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explain why microvessels leak, and biological studies are necessary to better understand the conse-
quence of this phenomenon. The healing response to this phenomenon could have consequences for
plaque remodeling and stability that could be studied using the lesion-specific modeling techniques
in this dissertation.
A final research question at the intersection of biology and mechanics is the role of WSS in
plaque progression. Atherogenesis is well-known to be associated with low magnitudes and oscil-
latory patterns of WSS, but those factors alone cannot explain plaque progression. Most lesions ex-
pand outward initially and preserve lumen diameter through Glagov remodeling, but when a lesion
begins to remodel inward, it forms a stenosis. This stenosis typically experiences high magnitudes
of WSS upstream but low magnitudes and oscillatory flow downstream, particularly as the severity
of stenosis increases. This process would seem to form a positive feedback loop of perpetually-
expanding lesion, but most people don’t have extensive lesions like this process ought to create.
There is more work yet to be done, especially with biomechanical techniques like those used in
this dissertation, to better understand exactly how atherosclerosis begins, progresses, and leads to
thrombosis.
6.5 Conclusion and Clinical Implications
Overall, this dissertation research demonstrates that plaque rupture in humans is biomechanically
unique when compared to plaque erosion and to plaque rupture in mice. We have shown that mouse
models of atherosclerosis do not seem likely to experience plaque rupture and may not be physio-
logically relevant for studying the phenomenon. We have shown that inflammation is not modulated
by mechanical strain in erosion as it is in rupture, which implies that clinical management of pa-
tients may need to be refined to account for a different etiology of thrombosis in erosion. Lastly,
we have shown that erosion does not seem to be associated with flow, which implies that additional
biological mechanisms should be considered to better understand the phenomenon.
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tween endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques.,”
Circulation, vol. 101, pp. 2450–3, May 2000.
[87] Taylor, C. a., Hughes, T. J., and Zarins, C. K., “Finite element modeling of three-
dimensional pulsatile flow in the abdominal aorta: relevance to atherosclerosis.,” Annals of
Biomedical Engineering, vol. 26, no. 6, pp. 975–87, 1998.
119
[88] Moore, J. A., Steinman, D. A., Prakash, S., Johnston, K. W., and Ethier, C. R., “A numer-
ical study of blood flow patterns in anatomically realistic and simplified end-to-side anasto-
moses.,” Journal of Biomechanical Engineering, vol. 121, no. 3, pp. 265–72, 1999.
[89] Moore, J. A., Steinman, D. a., Holdsworth, D. W., and Ethier, C. R., “Accuracy of computa-
tional hemodynamics in complex arterial geometries reconstructed from magnetic resonance
imaging.,” Annals of Biomedical Engineering, vol. 27, no. 1, pp. 32–41, 1999.
[90] Holliday, C. J., Ankeny, R. F., Jo, H., and Nerem, R. M., “Discovery of shear- and side-
specific mRNAs and miRNAs in human aortic valvular endothelial cells.,” American Journal
of Physiology. Heart and Circulatory Physiology, vol. 301, pp. H856–67, Sept. 2011.
[91] Moyle, K. R., Antiga, L., and Steinman, D. A., “Inlet conditions for image-based CFD
models of the carotid bifurcation: is it reasonable to assume fully developed flow?,” Journal
of Biomechanical Engineering, vol. 128, pp. 371–9, June 2006.
[92] Lee, S.-W., Antiga, L., and Steinman, D. a., “Correlations among indicators of disturbed
flow at the normal carotid bifurcation.,” Journal of Biomechanical Engineering, vol. 131,
p. 061013, June 2009.
[93] Panton, R. L., Incompressible Flow. Wiley, 3 ed., 2005.
[94] Lee, S.-W. and Steinman, D. A., “On the relative importance of rheology for image-based
CFD models of the carotid bifurcation.,” Journal of Biomechanical Engineering, vol. 129,
pp. 273–8, Apr. 2007.
[95] Sutera, S. P. and Skalak, R., “The History of Poiseuille’s Law,” Annual Review of Fluid
Mechanics, vol. 25, pp. 1–20, Jan. 1993.
[96] Womersley, J., “Method for the Calculation of Velocity, Rate of Flow and Viscous Drag
in Arteries when the Pressure Gradient is Known,” Journal of Physiology, vol. 127, no. 3,
pp. 553–563, 1955.
[97] Campbell, I. C., Ries, J., Dhawan, S. S., Quyyumi, A. a., Taylor, W. R., and Oshinski, J. N.,
“Effect of inlet velocity profiles on patient-specific computational fluid dynamics simulations
of the carotid bifurcation.,” Journal of Biomechanical Engineering, vol. 134, p. 051001, May
2012.
[98] Groen, H. C., Gijsen, F. J. H., van der Lugt, A., Ferguson, M. S., Hatsukami, T. S., van
Der Steen, A. F. W., Yuan, C., and Wentzel, J. J., “Plaque rupture in the carotid artery
is localized at the high shear stress region: a case report.,” Stroke; a Journal of Cerebral
Circulation, vol. 38, pp. 2379–81, Aug. 2007.
[99] Fukumoto, Y., Hiro, T., Fujii, T., Hashimoto, G., Fujimura, T., Yamada, J., Okamura, T., and
Matsuzaki, M., “Localized elevation of shear stress is related to coronary plaque rupture:
a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress
distribution.,” Journal of the American College of Cardiology, vol. 51, pp. 645–50, Feb.
2008.
[100] Beattie, D., Xu, C., Vito, R., Glagov, S., and Whang, M. C., “Mechanical analysis of het-
erogeneous, atherosclerotic human aorta.,” Journal of Biomechanical Engineering, vol. 120,
pp. 602–7, Oct. 1998.
120
[101] Humphrey, J. D. and Rajagopal, K. R., “A constrained mixture model for growth and remod-
eling of soft tissues,” Mathematical Models and Methods in Applied Sciences, vol. 12, no. 3,
pp. 407–430, 2002.
[102] Holzapfel, G. A., Sommer, G., Gasser, C. T., and Regitnig, P., “Determination of layer-
specific mechanical properties of human coronary arteries with nonatherosclerotic intimal
thickening and related constitutive modeling.,” American Journal of Physiology. Heart and
Circulatory Physiology, vol. 289, pp. H2048–58, Nov. 2005.
[103] Baek, S., Gleason, R., Rajagopal, K., and Humphrey, J., “Theory of small on large: Potential
utility in computations of fluidsolid interactions in arteries,” Computer Methods in Applied
Mechanics and Engineering, vol. 196, pp. 3070–3078, June 2007.
[104] Fung, Y., Biomechanics: Mechanical Properties of Living Tissues. Secaucus, NJ: Springer-
Verlag, 2 ed., 1993.
[105] Cheng, G. C., Loree, H. M., Kamm, R. D., Fishbein, M. C., and Lee, R. T., “Distribution
of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis
with histopathological correlation.,” Circulation, vol. 87, pp. 1179–87, Apr. 1993.
[106] Arroyo, L. H. and Lee, R. T., “Mechanisms of plaque rupture: mechanical and biologic
interactions.,” Cardiovascular Research, vol. 41, pp. 369–75, Feb. 1999.
[107] Versluis, A., Bank, A. J., and Douglas, W. H., “Fatigue and plaque rupture in myocardial
infarction.,” Journal of Biomechanics, vol. 39, pp. 339–47, Jan. 2006.
[108] Varnava, A. M., Mills, P. G., and Davies, M. J., “Relationship between coronary artery re-
modeling and plaque vulnerability.,” Circulation, vol. 105, pp. 939–43, Feb. 2002.
[109] Huang, H., Virmani, R., Younis, H., Burke, A. P., Kamm, R. D., and Lee, R. T., “The im-
pact of calcification on the biomechanical stability of atherosclerotic plaques.,” Circulation,
vol. 103, pp. 1051–6, Mar. 2001.
[110] Loree, H. M., Kamm, R. D., Stringfellow, R. G., and Lee, R. T., “Effects of fibrous cap thick-
ness on peak circumferential stress in model atherosclerotic vessels.,” Circulation Research,
vol. 71, pp. 850–8, Oct. 1992.
[111] Kilpatrick, D., Goudet, C., Sakaguchi, Y., Bassiouny, H. S., Glagov, S., and Vito, R., “Effect
of plaque composition on fibrous cap stress in carotid endarterectomy specimens.,” Journal
of Biomechanical Engineering, vol. 123, pp. 635–8, Dec. 2001.
[112] Williamson, S. D., Lam, Y., Younis, H. F., Huang, H., Patel, S., Kaazempur-Mofrad, M. R.,
and Kamm, R. D., “On the sensitivity of wall stresses in diseased arteries to variable material
properties.,” Journal of Biomechanical Engineering, vol. 125, pp. 147–55, Feb. 2003.
[113] Vengrenyuk, Y., Carlier, S., Xanthos, S., Cardoso, L., Ganatos, P., Virmani, R., Einav, S.,
Gilchrist, L., and Weinbaum, S., “A hypothesis for vulnerable plaque rupture due to stress-
induced debonding around cellular microcalcifications in thin fibrous caps.,” Proceedings of
the National Academy of Sciences of the United States of America, vol. 103, pp. 14678–83,
Oct. 2006.
121
[114] Maldonado, N., Kelly-Arnold, A., Vengrenyuk, Y., Laudier, D., Fallon, J. T., Virmani, R.,
Cardoso, L., and Weinbaum, S., “A mechanistic analysis of the role of microcalcifications in
atherosclerotic plaque stability: potential implications for plaque rupture.,” American Journal
of Physiology. Heart and Circulatory Physiology, vol. 303, pp. H619–28, Sept. 2012.
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